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Abstract: Coronary artery disease (CAD) is the most common cause of death 
worldwide making it one of the most important public health issues. For the 
surgical treatment of CAD, a number of patients, 400,000 in US alone, undergo 
coronary artery bypass grafting (CABG) each year, making it one of the most 
widely performed surgeries in the world. During my research fellowship at the 
Cleveland Clinic, I undertook a series of studies that sought to identify strategies 
and techniques that improve the short and long-term outcomes of this important 
procedure. Most of my work was focused towards studying the outcomes of 
CABG in diabetic patients because patients with diabetes represent an important 
and growing population of patients undergoing CABG. Through my research 
work I showed that 1) the patients most likely to benefit from CABG, compared to 
PCI, are the ones with extensive CAD & comorbidities (like diabetic patients), 2) 
the proportion of patients undergoing CABG who have diabetes has increased 
over the last four decades and diabetes is an independent risk factor for worse 
long-term survival after CABG (20 year survival after CABG: 18% in diabetic 
patients vs. 42% in non-diabetic patients), 3) diabetes does not influence the 
long-term patency of coronary artery bypass grafts and, therefore, worse long-
term survival after CABG in diabetic patients is likely not related to worse graft 
durability, 4) surgical revascularization techniques like bilateral internal thoracic 
artery (ITA) grafting compared to single ITA grafting and complete 
revascularization compared to incomplete revascularization are associated with 
better long-term survival in patients with diabetes undergoing CABG, and 5) 
bilateral ITA grafting and single ITA plus radial artery grafting are equally 
effective in terms of hospital outcomes and long-term survival for diabetic 
patients undergoing CABG. Through my research, I also demonstrated how real-
world data could be used to provide insights into appropriate strategies for 
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CAD: Coronary artery disease 
IHD: Ischemic heart disease 
CABG: Coronary artery bypass grafting 
PCI: Percutaneous coronary intervention 
ITA: Internal thoracic artery 
SV: Saphenous vein 
SITA: Single internal thoracic artery grafting 
BITA: Bilateral internal thoracic grafting 
RA: Radial artery 
FREEDOM: Future Revascularization Evaluation in Patients with Diabetes 
Mellitus: Optimal Management of Multivessel Disease 
CVIR: Cardiovascular Information Registry 








Ischemic heart disease, also known as coronary artery disease (CAD), is the 
most common cause of death worldwide [1] making it an important public health 
issue. Diabetes is a major risk factor for development of CAD [2-4]. Therefore, 
compared to individuals without diabetes, those with diabetes have a higher 
prevalence of CAD [5] which can lead to myocardial infarction and death.  
Treatment options for CAD include medical management, percutaneous coronary 
intervention (PCI), and coronary artery bypass grafting (CABG) surgery. For 
diabetic patients with complex multivessel CAD, CABG is the revascularization 
strategy of choice [6]. As the prevalence of diabetes has risen, CAD associated 
with it has also increased [3]. Today, diabetics represent an important and 
growing population of patients undergoing CABG [7]. It is, therefore, imperative 
to identify strategies that improve the outcomes of CABG in this important 
population so that the thousands of diabetic patients that undergo CABG each 
year could benefit from its improved outcomes.  
 
1.2 Coronary Artery Disease  
CAD refers to the buildup of plaque in the coronary arteries restricting blood flow 
to the heart. The impedance of blood flow to the heart can result in myocardial 




known as heart attack) and death. According to the World Health Organization 
(WHO), CAD is the leading cause of death worldwide [1]. It is responsible for 
killing over 370,000 people in the US [8] and 73,000 people in the UK annually 
[9]. According to the American Heart Association (AHA) 2017 statistics, about 
16.5 million American adults have CAD [10]. 
 
1.3 CABG: Statistics 
CABG is one of the most commonly performed major surgical operations in the 
world, with about 400,000 procedures performed in the US [11] and about 20,000 
performed in the UK annually [12].  
 
1.4 CABG: The Procedure 
During CABG a healthy artery or vein is taken from elsewhere in the body and is 
grafted (attached) to a blocked coronary (heart) artery. This allows the grafted 
artery to “bypass” the blocked or narrowed coronary artery, restoring the blood 
flow to the heart.  
 The most commonly used conduits used for bypass grafting include 
internal thoracic artery (ITA), saphenous vein, and radial artery. The internal 
thoracic arteries, also known as the internal mammary arteries, are located in the 
chest wall, one on each side, and have the best patency rates compared to other 
grafts [13,14]. In a typical CABG operation, the left anterior descending coronary 




coronary artery systems is done using right ITA, radial or saphenous vein grafts 
(based on the degree of stenosis, importance of vessel and surgeon preference).  
 A surgeon can perform CABG operation with or without the help of a 
heart-lung machine. When a surgeon performs CABG on a non-beating/stopped 
heart with the help of a heart-lung machine it is referred to as on-pump surgery, 
whereas, when a surgeon performs CABG on a beating heart without the help of 
a heart-lung machine, it is referred to as off-pump surgery.  
 If a surgeon is able to graft all coronary arteries with ≥50% stenosis (i.e. 
≥50% diameter narrowing based on visual angiographic assessment), it is 
referred to as complete revascularization, whereas, when a surgeon does not 
bypass all coronary arteries with ≥50% stenosis, it is referred to as incomplete 
revascularization (we used this definition of complete and incomplete 









Coronary-Artery Bypass Grafting. 
Shown are a left-internal-thoracic-artery graft to the left anterior descending 
coronary artery and saphenous-vein grafts to the left marginal and right coronary 
arteries. Reproduced with permission from Alexander JH, Smith PK. Coronary-
Artery Bypass Grafting. N Engl J Med. 2016;374(20):1954-64, Copyright 





Completed CABG Procedure.  
The surgery depicted involves a saphenous-vein graft from the aorta to the right 
coronary artery (RCA), an in situ graft from the left internal thoracic artery (LITA) 
to the left anterior descending coronary artery (LAD), a composite right-internal-
thoracic-artery (RITA) graft from the LITA graft to the circumflex coronary artery, 
and a radial-artery graft from the aorta to the diagonal coronary artery. 
Reproduced with permission from Jones DS. CABG at 50 (or 107?) - The 
Complex Course of Therapeutic Innovation. N Engl J Med. 2017;376(19):1809-




1.5 Diabetes & Coronary Artery Disease 
Diabetes is a growing epidemic affecting over 400 million people worldwide [15]. 
In the US alone, 30.3 million people have diabetes and another 84 million have 
prediabetes—a condition that, if not treated, can progress to diabetes in only 5 
years [16]. Moreover, the number of Americans with diabetes is projected to 
double or triple by 2060 [17].  
 There is a wealth of pathological and epidemiological data that shows that 
diabetes is a major risk factor for the development of various cardiovascular 
diseases including CAD, stroke, cardiomyopathy and renal disease [18]. CAD 
amongst these is of particular concern because it is the number 1 cause of death 
worldwide. The relative risk of myocardial infarction is 2- to 3-fold higher in 
diabetic patients compared to nondiabetics, independent of the presence of other 
known cardiovascular risk factors [19,20]. 
 CAD is caused by atherosclerosis [21]. The process of atherosclerosis 
starts by the adhesion of monocytes to the endothelial cells of arteries. The 
monocytes then transmigrate into the subendothelial space. These monocytes 
differentiate into intimal macrophages, which take up lipids (forming foam cells) 
and accumulate in the artery wall, resulting in accelerated fatty streak formation 
and triggering the production of the extracellular matrix. This leads to the 
formation of fibrous plaques which may rupture resulting in the clinical 




 Diabetes accelerates atherosclerosis [4]. Prolonged exposure to 
hyperglycemia and insulin resistance in combination with other risk factors such 
as obesity, dyslipidemia and hypertension play critical roles [20]. Insulin 
resistance in diabetic patients can alter lipid metabolism leading to the 
development of dyslipidemia which along with endothelial dysfunction (induced 
by aberrant insulin signaling) contribute to atherosclerotic plaque formation [23]. 
Hyperglycemia induces many alterations at the cellular level of vascular tissue 
that potentially accelerate the atherosclerotic process. These include: 1) non-
enzymatic glycosylation of proteins and lipids, 2) oxidative stress, and 3) protein 
kinase C activation. Oxidative stress induced by hyperglycemia can foster the 
formation of advanced glycosylation end-products and the activation of protein 
kinase C [4]. Another mechanism by which hyperglycemia can contribute to the 
progression of atherosclerosis involves the activation of the nuclear factor kappa-
light-chain-enhancer of activated B cells (NFκB) [24,25]. This can lead to the 
expression of inflammatory genes like those of adhesion molecules that facilitate 
the adhesion of monocytes to arterial endothelial cells [24].  
Studies have shown not only the increased prevalence of atherosclerotic plaques 
in diabetic patients but also the higher propensity of their rupture in these 
patients. A study based on angiographic data showed that among patients 
admitted to hospital with unstable angina, plaques were found to be ulcerated in 
94% of diabetic patients compared to 60% of non-diabetic patients, and 
intracoronary thrombus formation was observed in 94% of diabetic patients 




atherectomy specimens in diabetic vs. non-diabetic patients found greater 
macrophage infiltration, thrombosis and lipid content in the atheromas of diabetic 
patients [27]. All these features increase the vulnerability of a plaque to rupture, 
and the increased thrombogenesis & platelet dysfunction seen in diabetic 
patients worsen the resulting clinical consequences [19, 28, 29]. 
 A good share of our understanding of the pathophysiology of heart 
diseases come from the Framingham heart study [2,3]. It is considered a 
landmark study in cardiovascular sciences and is a long-term ongoing 
cardiovascular research on residents of the town of Framingham, 
Massachusetts, USA. This study started in 1948 with 5209 participants, and is 
now on its 3rd generation of adult subjects. This study also showed that risk of 
atherosclerotic disease is 2- to 3-fold higher in diabetic patients [2], with CAD as 
its main sequelae. Data from this study also suggests that duration of diabetes 
increases the risk of CAD and CAD-related death independent of coexisting risk 
factors [3].  
 The high prevalence of CAD in diabetic patients presents a significant 
burden of disease. The risk of death from CAD is higher in individuals with 
diabetes [3]. A patient with diabetes is not only at higher risk of developing CAD, 
but the disease accelerates much faster as compared to non-diabetic patients 
and the outcomes of treatments are not as good as those in non-diabetic patients 
[21,30]. Due to accelerated atherosclerosis, CAD in diabetic patients is also more 




ischemia in cardiac muscle due to CAD usually occurs without symptoms in 
patients with diabetes [33]. Therefore, multivessel CAD often is present before 
ischemic symptoms occur and before treatment is instituted. This delay further 
worsens the prognosis for survival for many diabetic patients [18].  As 
the prevalence of diabetes has risen, cardiovascular disease associated 
with it has also increased [3], making it an important area for current and future 
research efforts.  
 
1.6 Coronary Revascularization in Diabetic Patients: CABG vs. PCI 
With increasing diabetes prevalence, the proportion of patients undergoing 
coronary revascularization procedures who have diabetes has also increased [7, 
30]. A number of studies have shown superiority of CABG over PCI for coronary 
revascularization in diabetics. Data from the Bypass Angioplasty 
Revascularization Investigation (BARI) trial showed that diabetic patients who 
underwent PCI had almost a doubled 5-year mortality compared to diabetics who 
underwent CABG [34]. The Bypass Angioplasty Revascularization Investigation 2 
Diabetes (BARI 2D) study further showed that prompt revascularization by CABG 
significantly reduced major cardiovascular events in diabetic patients compared 
with intensive medical therapy alone [35]. The Coronary Artery Revascularization 
in Diabetes (CARDia) trial, which was the first randomized trial of coronary 
revascularization in patients with diabetes, failed to show superiority of CABG 
over PCI in diabetic patients. This trial, however, was underpowered to make this 




Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal 
Management of Multivessel Disease) demonstrated that CABG, rather than PCI, 
is the revascularization strategy of choice for diabetic patients with multivessel 
CAD [6]. This was an RCT that compared CABG and PCI with drug-eluting stents 
in patients with diabetes & multivessel CAD and found that patients who 
underwent CABG had significantly lower rates of death and myocardial infarction. 
A subgroup analysis from Synergy Between Percutaneous Coronary Intervention 
With TAXUS and Cardiac Surgery (SYNTAX) trial also showed survival benefit of 
CABG over PCI in patients with diabetes [37]. A meta-analysis from 8 trials, 
including 3,612 diabetic patients with multivessel stable CAD, showed that at 5-
years of follow-up, patients undergoing CABG had lower all-cause mortality than 
those undergoing PCI [38].  
 The explanation for these contrasting findings between outcomes of PCI 
and CABG may lie in the fundamental differences between the revascularization 
achieved by these two techniques. PCI treats lesions as they exist at the time of 
the procedure, relying in the long term on the coronary artery to remain patent 
distal to the stent. We know that beyond 1 year after stenting, new events result 
almost exclusively from the progression of disease in segments other than the 
stented lesion [39]. Compared with PCI, CABG brings a second source of blood 
flow to the distal coronary artery that, if it remains patent, is independent of 
possible proximal plaque rupture that may occur with time. Therefore, PCI treats 
only existing lesions and provides no protection against future lesions, whereas 




against future lesions. Moreover, CABG results in more complete coronary 
revascularization than PCI, particularly in patients with advanced and complex 
multivessel CAD, which is often observed in patients with diabetes.   
 Today, diabetic patients represent nearly 50% of all patients undergoing 
CABG in the United States [7]. Though the outcomes of CABG in diabetic 
patients are better than those of PCI, they are worse compared to outcomes of 
CABG in non-diabetic patients. Therefore, it is important to identify strategies and 
techniques that improve the outcomes of CABG in this important population.      
 
1.7 CABG in Diabetic Patients: Identifying Research Gaps 
The long-term durability of surgical revascularization is one of the key 
advantages that CABG has over PCI. A number of studies are available looking 
into the outcomes of CABG in diabetic patients, but there is dearth of literature 
evaluating long-term data, particularly outcomes beyond 10 years. For example, 
there are limited studies available studying the long-term angiographic outcomes 
(graft patency) after CABG in diabetic vs. non-diabetic patients. As mentioned in 
the systematic review section of chapter 4, the three studies available on this 
topic only report less than 10-year patency of bypass grafts in diabetic vs. non-
diabetic patients (also see section 10.3 in Appendix). No data is available 
regarding effect of diabetes on long-term (greater than 10 years) bypass graft 
patency. Similarly, studies reporting the long-term outcomes after different 
surgical techniques in diabetics, like off- vs. on-pump CABG, bilateral ITA (BITA) 




incomplete revascularization, are also limited (see sections 10.4 & 10.5 in 
Appendix). The studies included in the thesis attempt to fill these important gaps 
in the literature.  
 
 
1.8 Venue of Research Work 
 
All papers included in this thesis are based on the work that I did at the 
Cleveland Clinic during my research fellowship under the supervision of Dr. 
Joseph F. Sabik and Dr. Eugene H. Blackstone. Dr. Sabik was the Chairman of 
the Department of Thoracic & Cardiovascular Surgery from 2008 to 2016, and 
Dr. Blackstone is the Head of Clinical Investigations at the Heart & Vascular 
Institute of the Cleveland Clinic.  
 Cleveland Clinic is well known for heart surgery. Coronary angiography 
was developed in 1958 and CABG was pioneered in 1967 at the Cleveland 
Clinic. Since 1995, it is ranked number 1 in Cardiology and Cardiac Surgery 
according to U.S. News & World Report’s Best Hospitals 2018-19. 
 
1.8.1 HVI Clinical Investigations 
Clinical Investigations for the Heart & Vascular Institute (HVI) of the Cleveland 
Clinic is a multidisciplinary environment, with activities divided into prospective 
clinical registries, investigator-initiated studies, statistical and informatics 
methodology research, and research education. It is divided into two wings, both 
with card-swipe access to ensure protection of data. It is easily accessible to 




scholars. It is organized according to its major emphases, which means that 
large portions follow a data-flow model.  
 Our registry activity currently employs 27 workers, including 12 nurses, an 
MD MBA quality coordinator, and an RN education coordinator. Their duties 
include prospective data collection on all adult cardiothoracic surgery cases, 
cardiac catheterizations, interventional cardiology procedures, and long-term 
follow-up of selected cohorts. Our medical students, residents, fellows, NIH 
scholars, and faculty make extensive use of these data for research. In addition, 
the data are used for quality of care initiatives and internal and external reporting, 
such as to the Society of Thoracic Surgeons and the American College of 
Cardiology National Databases. This reporting and research activity are 
supported entirely by Cleveland Clinic’s institutional funds (approximately $4 
million per year of operational expenses and $1 million infrastructure capital).  
 Our investigator-initiated project team is headed by a PhD Clinical 
Research Administrator, a project manager, a PhD-level database analyst, 1 full-
time and 2 part-time statistical programmers, 4 full-time and 1 part-time MS-level 
statisticians and 1 full-time PhD-level statistician supervised by 2 Quantitative 
Health Sciences faculty members, and technical staff. These individuals work 
with the investigators through every stage of their research, from proposal 
development and refinement through presentation to the HVI Clinical 







1.8.2 Registries and Informatics 
A group of nurses, research assistants, and a physician concentrate on clinical 
registry activities, abstracting more than 500 variables from cardiac and thoracic 
surgery patients’ clinical records to form the core data elements for outcomes 
reporting, quality management, and investigator-initiated research. These data 
are entered into the Cardiovascular Information Registry (CVIR), a database that 
contains information on 250,000 patients and 125,000 cardiac operations. It is a 
prospective database updated concurrently with patient care. Founded in 1972, it 
is the largest and the longest continuous cardiovascular registry of its kind. 
Accuracy and availability of registry data are enhanced by the presence of a full-
time nurse manager, nurse educator, research project manager, and database 
personnel. One hundred percent of the outcomes are audited, and a random 
10% of cases are re-abstracted and data compared and adjudicated. The registry 
group also performs follow-up on 10,000 to 15,000 patients per year.  
 Our data abstractors are held to a 97% error-free rate at the time of their 
annual performance review to remain in a “fully meets” status. As of October 5, 
2018, the last time we were chosen for STS Adult Cardiac audit was 2017, and 
our agreement rate with the auditor findings was 97.7%. Our nurse abstractors 
and quality facilitators have clinical backgrounds in the focus of the registries 
they oversee. Education is ongoing, particularly when there is a version change 
in the registry, after each national meeting (Society of Thoracic Surgeons 
Advances in Quality & Outcomes; STS AQO), and when any patterns of error or 




“boot camp” for our affiliated sites (now open to all, not just affiliated sites) to 
learn our best practices in abstraction and teach the registry definitions of key 
fields like risk factors, procedure details, and targeted outcomes.  
 
1.9 Summary of Research Work 
The papers presented in this thesis are interrelated and build together a coherent 
body of work. The thesis follows a narrative linking the papers to build a picture. 
There is also a temporal angle, going from the first paper to the last, as the 
findings of the first project led to the conduct and execution of the second project 
and so on. It is also important to mention that all these projects were 
collaborative in nature and were conducted with the support of a multidisciplinary 
research team. Therefore, in recognition of the work of my colleagues I will be 
using the term “we” to describe design and findings etc.  
 The initial projects that I worked on when I joined the Cleveland Clinic had 
been started and designed by others before me but left unfinished. Moving them 
forward needed consistent effort given their complexity. I chose to work on some 
of such projects that fit with my overall research objectives, identified the 
remaining work and analyses needed, worked with the statisticians to complete 
the analysis, interpreted the data, and drafted papers and followed them to 
publication under the supervision of my mentors. One such paper is “Survival 
Prediction Models for Coronary Intervention: Strategic Decision Support” [40]. I 
included this paper in my thesis (presented in Chapter 2) because appropriate 




coronary revascularization. Other such projects that I worked on and took to 
publication are not included in the thesis either because they are not directly 
related to the theme of my thesis or I am not the lead author on them. All other 
papers included in the thesis (presented in Chapters 3 through 6) resulted from 
my primary projects at the Cleveland Clinic that were initiated by me (see section 
1.10 for details of my contribution to each paper).    
 The first research question that I attempt to answer in the thesis is: Which 
revascularization strategy, PCI or CABG, maximizes long-term survival for a 
given patient? The survival prediction model paper [40] mentioned in the 
preceding paragraph helps to answer this question. It shows that for patients with 
extensive CAD and comorbidities, like diabetic patients, CABG is associated with 
better long-term survival compared to PCI. This finding, and the findings of 
FREEDOM trial (described in section 1.6 above), made it imperative to look into 
the outcomes of CABG in diabetic patients in depth. The second paper 
(presented in Chapter 3) included in the thesis provides valuable data in this 
regard. In this paper we sought to determine the 4-decade (1972 to 2011) 
temporal trends in the prevalence of diabetes and cardiovascular risk factors 
among patients undergoing coronary surgery, and compare in-hospital outcomes 
and long-term survival after CABG in diabetic versus non-diabetic patients (see 
chapter 3) [41]. We found that the proportion of patients presenting for CABG 
who have diabetes increased each year during the past 4 decades, as did the 




long-term survival after CABG were worse in diabetic patients compared to non-
diabetic patients.  
 To investigate whether the worse outcomes of CABG in diabetic patients 
observed in previous study (presented in Chapter 3) were due to higher failure 
(occlusion) of bypass grafts in diabetic patients, we undertook a project to 
determine whether the occlusion of bypass grafts is higher in diabetic vs. non-
diabetic patients (see chapter 4) [42]. We found that occlusion of bypass grafts 
was similar in diabetic and non-diabetic patients, suggesting that the worse 
outcomes of coronary surgery in diabetic patients are likely not related to worse 
graft patency and could be due in part to diabetic patients having more 
comorbidities, as well as a progressive disease that leads to many complications.  
 One of the most important finding of our previous study (presented in 
Chapter 4) was that ITA grafts have excellent long-term patency in both diabetic 
and non-diabetic patients even 20 years after CABG. Because the effectiveness 
of CABG is directly related to long-term graft patency, one can hypothesize that 
use of two ITA grafts (BITA grafting) compared to using one ITA graft (SITA 
grafting), would lead to better long-term survival after CABG in diabetic patients. 
Therefore, in our next project (presented in Chapter 5), we tested this hypothesis 
[43] and found that use of two ITA grafts vs. one was associated with better long-
term survival but at the cost of increased risk of post-operative sternal wound 
infections. Therefore, we recommended in our paper that the use of two ITA 
grafts should be considered in all diabetic patients undergoing CABG whose risk 




 Because the use of two ITAs was associated with higher risk of sternal 
wound infections in our previous study (presented in Chapter 5), in our 
subsequent project (presented in Chapter 6) we sought to determine whether the 
use of one ITA plus a radial artery graft (SITA+RA grafting) yields outcomes 
similar to those of two ITA grafts (BITA grafting) in diabetic patients undergoing 
CABG [44]. We found that the long-term survival after CABG in diabetic patients 
was similar with these two arterial grafting strategies and concluded that in those 
diabetic patients whose risk of developing sternal wound infections is high, the 
use of one ITA plus a radial artery graft can be considered instead of using two 
ITA grafts, as both grafting strategies were associated with similar long-term 
survival. 
 It is important to note that CABG was pioneered at the Cleveland Clinic in 
1967 [45]. The work presented in this thesis is mostly based on patients who 
underwent primary isolated CABG at the Cleveland Clinic from 1972 to 2011. 
The long period of studies enabled us to evaluate the effect on outcomes of 
different surgical techniques that required passage of time to reveal their 
advantages or disadvantages. However, a lot has changed in these years in 
terms of patient case-mix and advances in surgical and medical therapy of CAD 
that may negate our findings, and their applicability to contemporary patients 
could be questioned.  
 There have been several advancements in surgical techniques over the 
course of these years including the use of two ITA grafts vs. one ITA graft, radial 




protection (some of these advancements are also the focus of the studies 
included in the thesis). There have been advancements in pre-operative and 
post-operative management like better understanding of risk factors of sternal 
wound infections, stroke and other post-operative complications leading to 
improvement in outcomes of CABG in recent years compared to earlier years. Of 
particular importance are the advances in medical therapy like the use of 
secondary preventive therapies after CABG. They play an important role in the 
management of patients recovering from CABG. These therapies slow the 
disease process and prevent adverse cardiac events both in the short and long 
term [46]. According to recent guideline statements [47,48], postoperative lipid-
lowering agents like statins & antiplatelet therapies like aspirin continue to be 
mainstays of secondary prevention. Statins decrease the progression of native 
coronary artery atherosclerosis, slow the process of atherosclerosis in vein 
grafts, and lower adverse cardiac events after CABG [46,47,49]. Aspirin lowers 
the risk of stroke, myocardial infarction, and vascular death in patients with CAD. 
Therefore, all CABG patients are candidates for long-term aspirin therapy [46].  
 To account for patient factors and medical advancements that may have 
changed over time and affected our study outcomes, but could not be included in 
the analyses, we used date of operation as a surrogate. However, the medical 
and surgical advances after the study periods could not be taken into 
consideration, so caution should be used when drawing conclusions about 




 It is also important to note that in all studies presented in the thesis, ≥50% 
stenosis was considered significant or clinically important as traditionally the 
presence of a 50% diameter stenosis has been used as the threshold value for 
treatment [50]. In several landmark studies too like the Veterans Administration 
(VA) Cooperative Study [51], BARI trial [52] and SYNTAX trial [53], a stenosis of 
50% was defined as significant or clinically important. However, it is important to 
note whether a stenosis is measured in terms of diameter or cross-sectional area 
because the two percentages do not correspond [54]. In our studies, and in the 
landmark studies mentioned above, a 50% stenosis that was considered 
significant refers to the ≥50% diameter narrowing of the coronary artery in 
question and this equates to a 75% cross-sectional area narrowing [54] because 
the 50% diameter narrowing and 75% cross-sectional area narrowing are related 
by the equation: cross sectional area = pi x square of radius. Compared to 
angiography, which provides a two dimensional luminal silhouette with little 
information about the vessel wall, intravascular ultrasound gives a cross-
sectional, three-dimensional image of the full circumference of the coronary 
artery [55] and, therefore, can be used to clarify ambiguous angiographic 
findings. However, it is not generally used in clinical practice because of the need 
for an operator experienced in its use and its expense [55]. The stenosis data 
used in all studies presented in this thesis is based on coronary angiography 
which represents the real-world approach as clinical decision making is virtually 





1.10 My Contribution to Research Projects 
Except for the first paper (basis of chapter 2), where my responsibilities were 
limited to step 6 and onwards, my responsibilities in all other papers included in 
the thesis were:  
1) Conceiving and designing the study 
2) Writing the proposal of each study 
3) Working with statisticians on development of analysis plan 
4) Working with database managers on the acquisition of data  
5) Collection of data not available in existing registries through review of 
patients’ charts 
6) Collaborating with statisticians for statistical analyses 
7) Interpreting the data  
8) Drafting the manuscript and seeing it through submission 
9) Presenting the study findings in scientific meetings 
10) Working on reviewer’s comments  
Co-investigators who collaborated on the projects and met ICJME guidelines 
of authorship were included as co-authors on studies.  
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Research Question 1—Which Revascularization Strategy, PCI or CABG, 
Maximizes Long-term Survival for a Given Patient? 
 
Based on Publication: Raza S, Sabik JF 3rd, Ellis SG, Houghtaling PL, Rodgers 
KC, Stockins A, Lytle BW, Blackstone EH. Survival Prediction Models for 




CABG vs. PCI has been a subject of debate among cardiologists and cardiac 
surgeons who treat patients with coronary artery disease (CAD) [1], and a 
number of studies compare these revascularization strategies [2-14]. Class 1 
evidence suggests that CABG is recommended for improving survival in patients 
with significant (³50% diameter) left main trunk stenosis; in those with significant 
(³70% diameter) stenosis in three major coronary arteries, with or without 
proximal left anterior descending involvement; and in those with significant 
(³70% diameter) stenosis in the proximal left anterior descending plus 1 other 
major coronary artery [15]. Contrary to these guidelines, a number of patients are 
revascularized with non-optimal strategies [16,17]. Furthermore, some patients 




needed as a cognitive aid to help identify the best revascularization strategy for 
these atypical patients.  
 A number of mathematical models are available to predict procedural or 
in-hospital mortality after PCI or CABG and to guide clinical practice [19-27]. 
However, there are very few risk models that can predict long-term survival after 
these procedures. Because the survival advantage of surgery becomes evident 
with time, it is important to have models capable of predicting which 
revascularization strategy—PCI or CABG—maximizes long-term survival for a 
given patient. Therefore, the first question that we sought to answer was to 
identify patients that would benefit more from CABG than PCI.  
 
2.2 Summary of Study Design & Methods 
From 1995 to 2007, 23,182 patients underwent primary isolated CABG 
(n=13,114) or first-time PCI with bare-metal stents (BMS; n=6,964) or drug-
eluting stents (DES; n=3,104) at the Cleveland Clinic.   
The study end point was time from intervention to all-cause mortality. Vital status 
after hospital discharge was obtained from routine anniversary follow-
up and supplemented with data from the Social Security Death Master File. 
Using these data, we developed variable-rich models for predicting 10-year 
survival after CABG and PCI with BMS and 5-year survival after PCI with DES. 
The models contained factors (25 variables) ranging from demographics to 
symptomatology to cardiac and noncardiac comorbidities. We then used these 




curves based on easily entered data to help physicians and surgeons make 
recommendations about interventional therapy for individual patients, and to 
inform patients of the survival risks and benefits of these therapies. We only 
studied long-term survival because other long-term outcomes data, such as 
quality of life and need of repeat revascularization after surgery vs. PCI, was not 
available for these patients.  
 
2.3 Summary of Results 
Using this tool, we found that many patients received therapy that was not 
optimal for their individual characteristics. We also found that patients most likely 
to experience a 5-year survival benefit from DES were those undergoing 
emergency revascularization for acute infarction, and patients most likely to 
benefit from CABG had extensive CAD and multiple comorbidities (like patients 
with diabetes; see Figure 4 and Table 2 of manuscript). We concluded that 
because treatment modalities for CAD are becoming more complementary than 
competitive, it is increasingly important to take a “heart team” approach to 
treatment to ensure that every patient receives the optimal therapy (heart team 
approach basically refers to the collaboration between cardiologists and cardiac 
surgeons to determine the best treatment plan for a given patient with heart 
disease). A variable-rich, programmed, decision-support tool based on detailed 
prediction models for prognosis after PCI and CABG would aid both cardiologists 
and cardiac surgeons in identifying the revascularization therapy that maximizes 




remember that computers are not doctors, and it is both impossible and unwise 
to take the human element out of the decision tree. A decision-support tool can 
be used, however, to confirm that we are not making biased or wrong decisions, 
and that we are offering each of our patients the best available information to 
allow them to make more informed decisions about their own health care. One 
may ask why we should keep humans in the decision process if humans are 
more prone to error than computers, especially a computational model that takes 
all important variables into account. One counter argument to this is that our 
model is based on observational data, so only measured confounders are 
accounted for in the model. Unlike randomized controlled trial data, unmeasured 
confounders are not accounted for in observational data.  
 
2.4 Findings Compared to Other Studies 
In 2012, two separate models were developed to predict 3-year survival after PCI 
and CABG using the STS and ACC databases, respectively [28,29]. One 
limitation of these models is that they are applicable only to patients over age 65. 
Moreover, they can only predict 3-year survival whereas our model can predict 
survival for up to 10 years.  
 MacKenzie et al [30] developed and internally validated models that 
accurately predict long-term survival after CABG and PCI using routinely 
available variables. To do so, they linked CABG and PCI data from northern New 
England registries on 35,000 patients, with complete data on risk factors, to the 




survival for up to 8 years after coronary revascularization. However, a major 
limitation of these models was that they were developed using PCI data from 
1992 to 2001 and thus do not account for advances in PCI, including use of drug 
eluting stents. 
 SYNTAX score is another available risk prediction tool. Although a high 
SYNTAX score suggests worse long-term outcomes after PCI, it does not 
influence surgical outcomes [31,32]. This is likely because it is based on 
coronary anatomy rather than patient characteristics such as age, diabetes, and 
renal failure, which are strong predictors of outcomes after CABG [31]. To 
address this, SYNTAX score II was developed which included important patient 
characteristics like age, ejection fraction, and creatinine clearance to predict 
survival up to 4 years [33]. Three things distinguish our model from SYNTAX 
score II. First, we have separately, although simultaneously, evaluated risk 
factors for death early after the procedure and later. The factors generally have 
different strengths in each of these eras, indicative of nonproportional hazards; 
SYNTAX score II assumes proportional hazards. Second, we have incorporated 
more clinical variables in our models, which tend to yield better predictions for 
patients with extremes of some variables, such as age, and combinations of 
variables (complex patients). Third, and a drawback of our model, is that 
SYNTAX score II includes the SYNTAX score itself, which is difficult to calculate 
retrospectively. This limitation is not so important for CABG, but is more 





2.5 Addition to Literature in Light of Systematic Review 
A systematic literature search was done to identify studies that already existed 
on this topic at the time of paper preparation/publication so that the addition to 
the literature that the study made could be effectively evaluated in the light of 
existing knowledge on the subject. Details of this systematic review are given in 
the Appendix (see section 10.1). Briefly, we searched the literature to identify 
prediction models that predict long-term survival after CABG vs. PCI to compare 
the strength and limitation of our risk model against those. Only models 
predicting long-term mortality/survival to at least 5 years after CABG and PCI 
were included. There was only one study identified that met the specified 
inclusion criteria. This study by MacKenzie and colleagues developed risk 
models for predicting short-term, mid-term, and long-term outcomes after PCI 
and CABG [30]. These models can predict survival after coronary 
revascularization out to 10 years. However, a major limitation is that they were 
developed using 1992–2001 data and thus do not account for advances in PCI, 
including use of DES. Our models can predict survival up to 10 years for CABG 
and BMS, and up to 5 years for DES and thus represent a valuable addition to 
the literature.  
 
2.6 Critical Commentary 





2.6.1 Rationale: When developing a clinical prediction model (CPM), it is 
recommended to explain the clinical context and rationale with references to 
existing prediction models [36]. One of the reasons for this is to avoid creating 
many redundant similar CPMs for the same clinical problem.  
 We developed prognostic models using patients who underwent coronary 
revascularization procedures. In the introduction section, we argued for 
developing a new CPM for long term mortality because existing ones only 
addressed short term in-hospital mortality. However, in the discussion section we 
cited five CPMs that assessed 3- to 10-year outcomes (references 32-37 of the 
paper). A reader might wonder whether updating or validating these existing 
CPMs was considered before it was decided to make a completely new CPM. 
Regarding this concern, we provided details in discussion section contrasting 
each available long-term model with our risk prediction tool and the need for 
developing a new one. However, we could have been clearer about this by 
putting some information about existing long-term models, and the rationale of 
developing a new one, in the introduction of the paper.  
 
2.6.2 Participant Selection: We used an appropriate data source, a good size (n 
= 23,183) cohort from our institution, for creating the CPM. We mentioned in the 
paper that patients undergoing PCI who had prior CABG were excluded but 
patients undergoing CABG who had prior PCI were included. We should have 




come to surgery after one or more PCI procedures, so keeping such patients in 
the study kept the decision tool closer to reality.  
 One of the limitations of this study was that it was based on observational 
data. To provide decision support and to inform patients about the comparative 
survival outlook of each therapy, a CPM based on data from a randomized 
controlled trial would have been ideal. However, randomized controlled trials are 
not always feasible for studying comparative effectiveness of surgical therapies 
because of lack of equipoise. Moreover, for predicting long-term survival after 
CABG and PCI, long-term follow-up data is needed which is often not feasible to 
obtain in clinical trials due to lack of resources and loss-to-follow-up due to 
various reasons.  
 
2.6.3 Outcomes: The time from intervention to death was a sensible outcome. 
We mentioned that vital status was obtained from routine anniversary follow-up 
supplemented with data from the Social Security Death Master File. A reader 
might question whether the routine anniversary follow-up was used to verify 
outcomes of all patients and if this was not the case, were there outcomes that 
were only verified by Social Security Death Master File. This is a very important 
issue because incomplete or differential verifications can influence the results 
(verification bias). I think we could have provided more details of the follow-up in 
our study, particularly about the routine anniversary follow-up. Median follow-up 
was provided for long-term mortality along with mean follow-up as the distribution 




regarding critical commentary on our follow-up. 
 
2.6.4 Predictors: Reading our paper, a reader might think that little details were 
provided regarding the analysis and identification of predictors. How and when 
were the predictors assessed? What were the definitions of predictors? These 
are some of the crucial items needed to judge the validity of a derivation study. 
More details regarding variable selection and identification of risk factors would 
have been beneficial.  
 To identify risk factors for death, multivariable analyses were performed in 
the multi-phase hazard function domain for each of the three groups separately. 
Variables considered in the analysis were listed in the appendix of the paper. 
Variable selection utilized bootstrap bagging with resampling of 500 datasets, 
and identification of variables with automated forward selection and retention of 
variables in the models with p≤0.05. All variables with bootstrap reliability of 50% 
or greater were retained in the guided analysis. In addition to these reliable 
factors, at least one variable representing every cluster of variables was also 
added since these are predictive models and parsimony was not the goal. Three 
separate predictive survival models were created, one for CABG, a second for 
PCI with DES, and a third for PCI with BMS. 
 
2.6.5 Sample Size: Sample size calculation was not done. This was a 
retrospective cohort study of patients who underwent primary isolated CABG and 




sample size calculation would not have affected the number of patients included. 
A common misconception is that the larger the study group, the larger the 
amount of information available for analysis of an event. For outcome events, the 
effective sample size is number of events, not total study size. Thus, sufficient 
data means a sufficient number of events associated with individual risk factors 
(37). Therefore, we should have provided more information regarding the number 
of predictors considered initially in the analysis and the number of patients with 
outcome events (i.e. death) to determine whether the sample size was adequate. 
Because all predictors mentioned in Appendix of the paper were considered 
initially, one could say that it is highly likely that the sample size was inadequate 
particularly for the DES model (n=3201). Based on empirical data, a general rule 
of thumb is 10 outcome events are needed for each continuous predictor variable 
and for each level of categorical variables initially considered (not only predictors 
in the final model) [38]. There were more than 60 predictors mentioned in the 
Appendix of the paper. If all of them were considered initially, we needed at least 
600 outcome events. This can lead to overfitting of model. Usually, carefully 
justifying predictor variables likely to be associated with the outcome, using large 
enough sample size for the number of predictors tested, and conducting internal 
validation can prevent or reduce overfitting problem. Another disadvantage of 
“predictor-rich” models is that they are not necessarily user-friendly.  
 Table 1 of paper shows that there were some missing data. We could 
have provided more information regarding handling of missing data (for e.g. 





2.6.6 Data Analysis: Throughout the paper, we drew causal inference based on 
observational data, which was not appropriate given the study design. Risk-
adjustment in observational studies can control for measured factors but not 
unknown factors. For drawing causal inferences, data from an RCT should have 
been used.  
 Predictive performance was not reported (e.g. discrimination, calibration). 
Without the model specification and how to calculate the risk, it is not possible for 
these models to be externally validated or implemented in clinical practice.  
 It was also not mentioned whether imputation for missing values was 
performed. We did impute for missing values in the analysis.  
 It was not clearly stated why a multiphase hazard model was used instead 
of the usually applied Cox regression model. We used a multiphase hazard 
model instead of the Cox model because the Cox model is proportional in 
hazard, an assumption usually made, but often not realistic. We chose a 
multiphase hazard model because it non-arbitrarily decomposes hazard into 
time-overlapping temporal components based on the data and permits 
simultaneous assessment of risk factors (like diabetes and no diabetes) in 
discrete time-based phases. This method allows to assess non-proportional 
hazards, a feature that is common to interventional and surgical procedures (like 
CABG) that carry transiently high early risk that falls rapidly to a much lower level 
after a variable duration of recovery, and later rises.  




confidence limits was not provided. As nicely explained in the Chapter 6 of the 
Kirklin/Barratt-Boyes textbook, Cardiac surgery [39], the confidence limits are 
frequently used as scanning tools to help predictions and comparisons, either of 
proportions or time-related depictions. If only moderate certainty is desired that 
the evident difference is a true difference and would be found in larger samples, 
50% confidence intervals might be chosen. However, if great certainty is required 
in the inference that there is a difference between two proportions of time- related 
depictions, 95% confidence intervals may be chosen for the comparisons. Most 
situations in cardiac surgery seem to lie somewhere between these extremes, so 
the use of 70% confidence limits for most comparisons is reasonable. 
Confidence limits of 70% (actually 68.3%) are equivalent to 1 standard deviation, 
and confidence limits of 95% to 2 standard deviations. For consistency, if other 
numeric estimates are presented to 1 standard deviation, 70% confidence limits 
should be used, and if 2 standard deviations are presented, 95% confidence 
limits should be used. We recommend consistency because we believe surgeons 
should become acquainted with using confidence limits as a scanning tool. To 
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Supplemental (Online-Only) Material 
 
Appendix: Variables Considered in Multivariable Analyses  
 
Demography  
Age (years)*, sex*, race, height (cm), weight (kg), body surface area (m2), body 
mass index (kg•m-2)*, diastolic blood pressure (mmHg)*, systolic blood pressure 
(mmHg)*, heart rate (beats•min-1) 
 
Pre-procedure status  
New York Heart Association functional class (I-IV), Canadian Angina class (I-IV), 
emergency operation* 
 
Left ventricular function  
LV dysfunction grade (none [EF≥60%], mild [EF 40%-50%], moderate [EF 25%-
39%], severe EF <25%]), previous myocardial infarction*, ejection fraction (%)*, 
LV aneurysm 
 
Pathology   
MV regurgitation*, MV regurgitation severity (0, 1+, 2+, 3+, 4+), MV stenosis, AV 
regurgitation, AV regurgitation severity (0, 1+, 2+, 3+, 4+), AV stenosis 
 




Pre-procedure atrial fibrillation*, number of coronary systems with ≥50% 
stenosis*, LAD*, LMT*, RCA*, LCx* stenosis (≥50%, ≥70%, any), family history of 
coronary artery disease, ventricular arrhythmia, complete heart block, 
endocarditis, heart failure*, cardiogenic shock, previous cardiac operation, 
previous PCI , unstable angina*  
 
Noncardiac comorbidity  
Treated diabetes*, hypertension*, previous stroke*, chronic obstructive 
pulmonary disease*, history of renal failure*, history of smoking*, calculated 
preoperative glomerular filtration rate and pre-procedure creatinine clearance, 
history of malignancy* 
 
Procedural   
CABG, PCI (bare metal or drug-eluting stent), number of stents placed, number 
of internal thoracic artery grafts, LAD drug-eluting or bare metal stent, LCx drug- 
eluting or bare metal stent, RCA drug-eluting or bare metal stent, LMT drug- 
eluting or bare metal stent, graft to LAD, graft to diagonal, graft to LCx, graft to 
RCA 
 
Pre-procedure laboratory data   
Total cholesterol (mg•dL-1), high-density lipoprotein (mg•dL-1), low-density 
lipoprotein (mg•dL-1), triglycerides (mg•dL-1),  blood urea nitrogen (mg•dL-1), 






Date of intervention*, interventionalist 
 
Outcomes   
Death, time from intervention until death 
 
_________________________________ 
Note: Asterisks indicate variables included in propensity scores. 
 
Key: AV=aortic valve; CABG=coronary artery bypass grafting; 
ECG=echocardiogram; LAD=left anterior descending coronary artery; LCx=left 
circumflex coronary artery; EF=ejection fraction; LMT=left main trunk; LV=left 










Research Question 2—What are the Outcomes of CABG in Diabetic 
Patients Compared to Non-diabetic Patients? 
 
Based on Publication: Raza S, Sabik JF 3rd, Ainkaran P, Blackstone EH. 
Coronary Artery Bypass Grafting in Diabetics: A Growing Health Care Cost 
Crisis. J Thorac Cardiovasc Surg. 2015;150(2):304-2.e2.  
 
3.1 Rationale  
Diabetes is a growing epidemic affecting over 400 million people worldwide [1]. 
Because coronary artery disease (CAD) is common in diabetics [2], it is an 
important driver of diabetes-related healthcare costs [3]. As the prevalence 
of diabetes has risen, cardiovascular disease associated with it has also 
increased [4]. Today, diabetics represent an important subset 
of patients undergoing coronary artery bypass grafting (CABG), an expensive 
procedure. Therefore, the second question that we sought to answer was: What 
are the outcomes of CABG in diabetic patients compared to non-diabetic 
patients? For this, we determined the 4-decade temporal trends in prevalence of 
diabetes and cardiovascular risk factors for patients undergoing 
CABG, compared overall in-hospital adverse outcomes, hospital resource 




diabetics. We then compared these in diabetics vs. non-diabetics with a similar 
high-risk profile using propensity-matching.   
 
3.2 Summary of Study Design and Methods 
This study included 57,278 patients from January 1, 1972, to January 1, 2011, 
who underwent first-time isolated CABG at the Cleveland Clinic. Data on the 
presence or absence of pharmacologically treated diabetes mellitus (insulin or 
oral hypoglycemic agent) were available for 55,501 (97%) of these patients—
45,139 non-diabetics and 10,362 diabetics. Patients were identified, and 
preoperative, operative, and postoperative variables (see Appendix E1 of the 
paper) were retrieved from the prospective Cardiovascular Information Registry 
(CVIR) of the Cleveland Clinic. This database is populated concurrently with 
patient care and has been approved for use in research by the Institutional 
Review Board, with patient consent waived.  
 The endpoints were in-hospital adverse events, resource utilization, and 
long-term survival. Actual direct technical cost data (not charge data), exclusive 
of physician professional salaries, were obtained from the Decision Support 
Services of the Cleveland Clinic. Data were available for patients only from 2003 
onward (n=4,679: 1,776 diabetics and 2,903 non-diabetics). Costs were 
corrected to constant 2011 dollars.  
 Vital status after hospital discharge was obtained by routine anniversary 






3.3 Summary of Results 
This study shows that the proportion of patients presenting for CABG who have 
diabetes increased each year over the last 4 decades, as did the proportion with 
cardiovascular risk factors (see Figure 1 of manuscript). Thus, compared with 
diabetics undergoing the operation in the 1970s, 1980s, and 1990s, those 
operated on more recently were more likely to be obese and present with more 
comorbidities and advanced CAD. CABG was more resource intensive and 
expensive in diabetics (see Figure 2 of manuscript), and in-hospital adverse 
events and long-term survival were worse for diabetics as well (see Figure 3 of 
manuscript). However, the increase in in-hospital resource utilization was not 
specific to diabetics, but was commensurate with that of patients coming to 
surgery with similar extent of comorbidities, but without diabetes. Unadjusted in-
hospital and early mortality (1-year) were higher in diabetics than in non-
diabetics, but similar for propensity-matched patients with a similar comorbidity 
profile. Long-term survival was worse in diabetics than in both non-diabetic 
patients and matched non-diabetic high-risk patients. Thus, diabetes is both a 
marker for high-risk, resource-intensive, and expensive care after CABG and an 
independent risk factor for reduced long-term survival.   
 
3.4 Findings Compared to Other Studies  
Other studies have also revealed worse hospital and long-term outcomes of 




little effect on outcomes of CABG, and diabetes control (as indicated by baseline 
hemoglobin A1c levels) was not predictive of major adverse cardiac and 
cerebrovascular events. In our study, overall postoperative prevalence of stroke 
and in-hospital death were higher in diabetics, and occurrence of myocardial 
infarction was higher in non-diabetics. However, after comparison with similar 
high-risk non-diabetic patients, occurrence of death and myocardial infarction 
was similar in the 2 groups, as was true in the SYNTAX trial, but stroke remained 
higher in diabetics [6].   
 Diabetic patients as a group had a higher early (1-year) risk of death after 
CABG than non-diabetic patients, as has been documented by others [5]. 
However, an interesting finding of our study is that among propensity-matched 
patients, early risk was similar to that of non-diabetic high-risk patients with a 
similar comorbidity profile. However, long-term survival was worse in diabetics 
compared with both non-diabetic patients and non-diabetic high-risk patients. 
Other studies have also demonstrated that diabetes is an independent risk factor 
for reduced long-term survival after CABG [5,8].  
 Other studies have also shown the association of diabetes with increased 
cost of CABG. These studies are discussed in the following section.  
 
3.5 Addition to Literature in Light of Systematic Review 
A systematic literature search was done to identify studies that already existed 
on this topic at the time of paper preparation/publication so that the addition to 




existing knowledge on the subject. Details of this systematic review are given in 
the Appendix (see section 10.2). Briefly, we search the literature for studies 
reporting the cost of CABG in diabetic vs. non-diabetic patients. Studies only 
reporting the cost of CABG in either diabetic or non-diabetic patients, and not in 
both patient populations, were excluded. Only three studies [8-10] were identified 
which met the specified criteria.  
 All three studies reported higher cost of CABG in diabetic vs. non-diabetic 
patients similar to the results of our study. What distinguishes our study from 
these existing studies, and constitutes a valuable addition to existing literature, 
are the details of the components of total direct technical cost. Moreover, we had 
a much higher sample size compared to all three studies (55,501 patients vs. 312 
in the study by Stewart et al [9], 605 in the study by Abizaid et al [10], and 9240 
in the study by Zhang et al [8]. Apart from reporting the differences in total direct 
technical cost in diabetics vs. non-diabetics, we also reported the differences in 
the cost of its component parts which included the cost of anesthesia, surgery, 
cardiology, respiratory therapy, professional services, imaging, nursing, 
pharmacy, laboratory and miscellaneous. We found that the total cost of CABG 
was 9% greater (95% CI, 7%-11%) in diabetics. Most of this difference was due 
to higher costs of clinical and laboratory testing, diagnostic imaging, pharmacy 
services, and nursing care. As mentioned in the paper, greater severity of 
disease among diabetics necessitates preoperative admission and more 




diabetics necessitates preoperative admission and more extensive laboratory 
and diagnostic workup. 
 The study by Stewart et al (n=312; diabetic, 114) showed that hospital 
charges of CABG were higher in insulin-treated diabetics vs. non-diabetic but 
similar in non-insulin treated diabetics vs. non-diabetics. In their study, only the 
total hospital charges were reported which were calculated from the day of 
operation.  
 The study by Abizaid et al (n=605; diabetic, 96) showed that 1-year cost of 
CABG was higher in diabetic patients compared to non-diabetic patients. In their 
study only procedural, follow-up and total cost was reported.  
 The study by Zhang et al (n=9240; diabetic, 2682) showed that at 2 years 
after CABG, costs for diabetic patients were higher than for non-diabetic patients. 
In their study in-hospital costs were reported which included diagnostic, 
procedural, and postprocedural costs. Follow-up costs were limited to 
cardiovascular rehospitalizations and medication costs.  
 
3.6 Critical Commentary  
Help was taken from the Critical Appraisal Skills Program (CASP) checklist for 









3.6.1 Rationale  
The study rationale was clearly mentioned in the introduction section of the 
paper. However, our objective did not make it clear whether the study was trying 
to detect the beneficial or harmful effect of diabetes on outcomes of CABG.  
 
3.6.2 Study Design 
It is critical to determine whether the chosen study design is appropriate for the 
question under study. Generally, an RCT is regarded as the best form of 
epidemiological study. However, an RCT is not always possible. The strength of 
RCTs lies in the process of randomization and in certain cases randomization is 
not possible, like in the cases of diabetic and non-diabetic patients undergoing 
CABG—one cannot randomize patients to diabetes or non-diabetes groups. 
Therefore, to study the 4-decade temporal trends in prevalence of diabetes and 
cardiovascular risk factors for patients undergoing CABG, and the outcomes of 
CABG in diabetic and non-diabetic patients, a retrospective cohort study is 
appropriate. Moreover, studying long-term survival (>20 years) after CABG in 
diabetic and non-diabetic patients would require a very long follow-up period, 
which is challenging, if not impossible.  
 
3.6.3 Participant Selection  
We used data from CVIR, which is a well-regarded registry in cardiac surgery 
literature. This registry has been the basis of many landmark studies [11,12]. 




from the same registry i.e. CVIR. Patients with unknown diabetic status were 
excluded. Patients were labelled as diabetic if they were on insulin or taking oral 
medications for diabetes, as mentioned in the paper. We chose patients 
undergoing first-time isolated CABG and excluded patients undergoing re-
operative CABG. This was appropriate as the two patient populations are 
different. Patients undergoing reoperative CABG are older, sicker and have more 
comorbidities [13]. Patients undergoing CABG with other concomitant surgical 
procedures like CABG plus aortic valve replacement (AVR) were also excluded. 
This was appropriate as the primary objective of the study was just to study the 
outcomes of coronary surgery. One of the limitations of the study was that we 
were unable to discriminate between type I and type II diabetes. This maybe 
important as the long-term survival after CABG of type 1 diabetic patients is 
worse than the survival of type II diabetic patients. However, this was not 
mentioned in the limitations section of the paper.  
 It was also not mentioned in the paper whether this study required any 
additional data-collection, apart from the data retrieved from CVIR. No additional 
data was collected for this study.  
 
3.6.4 Sample Size  
Sample size calculation was not done. This was a retrospective cohort study of 
consecutive patients who underwent primary isolated CABG at the Cleveland 
Clinic during a given time period. Therefore, sample size calculation would not 




determine whether the study was powered to detect a difference in outcomes, 
particularly long-term survival, after CABG in diabetic vs. non-diabetic patients, 
under the assumption that one exists. Our study showed that the 20-year survival 
after CABG was 20% for diabetic patients and 32% for non-diabetic patients. To 
detect this difference, our propensity-matched comparison was 100% powered, 
at a significance level of 5% (with 8926 patients in each group). Please note that 
some criticize the idea of retrospective power calculation. However, it was done 
just to provide an approximate idea regarding the statistical power of the study.  
 
3.6.5 End-points 
The studied end-points were defined clearly. These included in-hospital 
outcomes, resource utilization, and long-term mortality. Hospital outcomes were 
retrieved from CVIR. Please see 1.5.2 for details regarding data abstraction 
process for this registry and the accuracy of data collected—this information was 
not provided in the paper. The follow-up was long enough. Median follow-up was 
provided for long-term mortality as distribution of survival data is usually 
(positively) skewed. Although we mentioned in the paper that vital status was 
obtained by routine anniversary follow-up questionnaires supplemented with data 
from the Social Security Death Master File, we could have provided more 
information about the follow-up process. The following paragraph gives a detailed 
account of the follow-up in our studies.  
 CVIR systematic anniversary follow-up started in the early 1970s and 




emergent patients undergoing primary isolated CABG. Follow-up information was 
obtained using standardized questionnaires by mail and telephone calls from 
trained personnel.  The follow-up was performed at 5-year intervals for up to 25 
years after CABG. This routine follow-up of CABG patients was eventually 
stopped. The last primary isolated CABG cohort to be followed included patients 
undergoing primary isolated CABG in 1997. One of the limitations was that the 
circumstances of each death, which may be different between diabetic and non-
diabetic patients, were not reliably captured during the follow-up inquiries.  
 The follow-up information obtained through CVIR routine anniversary 
follow-up was supplemented with data from the US Social Security 
Administration’s Death Master File (SSDMF), usually called the “Social Security 
Death Index” in medical literature. This used to be an important source of vital 
status for clinical researchers as it was sensitive, specific, inexpensive and up-to-
date. However, it is no longer available for medical research since November 
2011 and therefore could not be used for new projects [14]. The master file 
contains all deaths occurring in the United States or its territories (foreign or not). 
However, this file is only a file of deaths. Thus, if a person is not listed in the 
SSDMF, one assumes that person is alive. This creates errors on each side with 
approximately equal frequency. It amounts to about 2% error both ways. 
Furthermore, it provides only all-cause mortality—therefore, we do not know 






3.6.6 Data Analysis  
Use of Multiphase Model vs. Cox Model: Survival was assessed non-
parametrically using the Kaplan-Meier method and parametrically using a 
multiphase hazard model. The latter involved resolving the number of hazard 
phases for instantaneous risk of death (hazard function) and estimating shaping 
parameters [15]. The details regarding the use of a multiphase hazard model vs. 
the Cox model are given in section 2.6.6 above. 
 
Confounding: As mentioned in the paper, the patient characteristics significantly 
differed between the two groups, patients with and without diabetes. To adjust for 
the imbalances in measured characteristics and for fair comparison of outcomes, 
we performed matching based on propensity scores [16]. A number of variables 
(detailed in the appendix of the paper) were considered in this analysis ranging 
from demographic variables, to cardiac and non-cardiac comorbidities, and date 
of operation. However, any patient factors not included in the propensity model 
that importantly affect outcomes might have biased our findings. 
 
Propensity Scores: Because patient characteristics differed between diabetic and 
non-diabetic groups, we attempted to fairly compare outcomes using propensity 
score matching. Propensity scores are the most commonly used balancing 
scores. They provide for each patient in the study an estimate of the propensity 
toward (probability of) belonging to one group versus another (group 




logistic regression or random forest classification method, it can be used in 
several ways for balancing. These include matching, inverse weighting, 
stratification and multivariable adjustment. We used matching because it 
eliminates a greater proportion of the systematic differences in baseline 
characteristics between the comparison groups of interest compared to 
stratification or multivariable adjustment. However, regarding the use of matching 
vs. inverse weighting, some studies show similar effectiveness and some show 
slight advantage of matching over inverse weighting [17]. A problem with inverse 
weighting is that at the tail ends of propensity score, patients are over-weighted, 
a well-known drawback of this method. Liang Li and colleagues [18] created a 
new weighting scheme that avoids the end-effects. Our statisticians did not use it 
for my studies, but are using it increasingly now and find that the resulting “virtual 
pairs” (obtained by analyzing fractional patients, just as in inverse weighting) tend 
to be even closer together than by traditional pairwise matching. Therefore, if I 
conduct a similar study again, I would use this technique instead of pairwise 
matching.  
 
Variable Selection: As pointed out by Dr. David Naftel, different investigators 
sometimes produce different multivariable models from the same data [19]. In a 
1983 Scientific American article, Diaconis and Efron [20] show that if one 
generates a new dataset by sampling with replacement from the original dataset 
(now called a bootstrap sample), repeats this many times, and then performs a 




time. Multivariable models are fragile and generally unreproducible. However, as 
explicitly found by Sauerbrei and colleagues [21], by “averaging” over the 
different models, one can obtain a stable model, separating signal from noise 
[22]. Thus, in constructing our multivariable models, we used automated 
stepwise variable selection on 250 to 1000 bootstrap samples (depending on the 
study), and selected those variables appearing in at least 50% of models at 
P<.05 (as suggested by Breiman [23] to balance Type I and Type II error). 
 
Use of 68% Confidence Limits vs. 95% Confidence Limits: For explanation 
regarding use of 68% confidence limits, please see section 2.6.6 above.  
 
3.6.7 Results & Discussion 
 The long-term survival was reported for up to 20 years. The results look 
precise given the range of the confidence intervals provided in the results and 
figures of the manuscript. However, measures like absolute risk reduction and 
hazard ratio were not reported in the manuscript. The results are believable 
because the study compared outcomes in a large number of diabetic and non-
diabetic patients using data from a well-regarded registry and took appropriate 
measures to control for confounding.  
 The Discussion clearly mentioned the principal findings of the study, and 
in the section of “findings in context”, we discussed the existing knowledge on the 
topic and compared our findings with the results of other studies. The limitations 




results may not be generalizable. Nevertheless, with the increasing proportion of 
patients with diabetes undergoing CABG, and with the widespread experience 
with CABG these days, our experience should be repeatable in other centers that 
see diabetic patients in need of CABG.  
 The conclusions of the paper were supported by the data presented and 
mentioned the clinical implications of the study instead of just summarizing the 
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Research Question 3—What is the Influence of Diabetes on Long-term 
Patency of Bypass Grafts?  
 
Based on Publication: Raza S, Blackstone EH, Houghtaling PL, Rajeswaran J, 
Riaz H, Bakaeen FG, Lincoff AM, Sabik JF 3rd. Influence of Diabetes on Long-
term Coronary Artery Bypass Graft Patency. J Am Coll Cardiol. 
2017;70(5):515-524.  
 
4.1 Rationale  
One of the findings of our previous study (presented in Chapter 3) was that long-
term survival after CABG was worse in diabetic patients compared to non-
diabetic patients. Therefore, we did this study to investigate whether worse long-
term survival after CABG in diabetic vs. non-diabetic patients was due to higher 
failure (occlusion) of bypass grafts in diabetic patients. At the time of execution of 
this study, little was known about the long-term patency of bypass grafts in 
diabetic vs. non-diabetic patients and the few available studies showed 
conflicting results [3-8]. We hypothesized that because diabetic patients have 
more severe coronary artery stenosis [9,10], stenosis in their bypass grafts would 
also be more severe than in non-diabetic patients, resulting in lower graft 
patency. To test this hypothesis, we compared patency of the two most 




veins (SV)—in diabetic vs. non-diabetic patients. Therefore, our third research 
question sought to answer: What is the influence of diabetes on patency of 
bypass grafts? 
 
4.2 Summary of Study Design & Methods 
This study included 1,372 pharmacologically treated diabetic patients and 10,147 
non-diabetic patients who underwent primary isolated CABG at the Cleveland 
Clinic from 1972 to 2011 and had at least one postoperative angiogram available. 
Stenosis was quantified for 7,903 ITA grafts and 20,066 SV grafts. Grafts, 
particularly SV grafts, tended to be either completely patent or occluded (Figure 
2). Therefore, for analysis of this bimodal distribution, a graft was defined as 
patent if it was not occluded on follow-up angiography. The status of graft 
patency across time was analyzed by longitudinal nonlinear mixed-effects 
modeling.  
 In order to explore the possible influence of cardiac death on longitudinal 
estimates of graft patency, we performed a pattern-mixture sensitivity analysis to 
estimate patency trends separately for patients who experienced a cardiac death 
and patients alive at the time of follow-up closing date.  
 The possibility of work-up bias affecting the estimates of graft patency was 
also assessed because diabetic patients tend to be clinically followed for their 
diabetes more closely than non-diabetic patients.  
 We did not know the indication for postoperative angiography on a case-




symptoms. Therefore, it could be argued that the results of the study would be 
applicable only to patients with ischemic symptoms who undergo angiography 
and may not be generalizable to the entire CABG population. To account for this, 
we studied the influence of diabetes on the patency of bypass grafts in a subset 
of patients who underwent a single planned angiography 1 year after surgery. 
Moreover, using the multivariable model for graft occlusion for the overall study 
population, the predicted occlusion at 1 year was calculated for patients 
undergoing a single planned angiography and compared with the actual 
occlusion for this population. 
 
4.3 Summary of Results 
We studied 20,066 SV grafts and 7,903 ITA grafts and found no influence of 
diabetes on ITA or SV graft patency over more than 20 years, contrary to our 
hypothesis. ITA graft patency was stable over time and similar in diabetic and 
non-diabetic patients: at 1, 5, 10, and 20 years, 97%, 97%, 96%, and 96% in 
diabetic and 96%, 96%, 95%, and 93% in non-diabetic patients, respectively 
(early P=.2, late P=.3; see Figure 4 of manuscript). In contrast, SV graft patency 
declined over time, similarly in diabetic and non-diabetic patients: at 1, 5, 10, and 
20 years, 78%, 70%, 57%, and 42% in diabetic and 82%, 72%, 58%, and 41% in 
non-diabetic patients, respectively (early P<.002, late P=.6; see Figure 4 of 
manuscript). The patient characteristics associated with worse graft patency 
included women vs. men, younger age, asymptomatic patients, and higher 




included using an ITA to graft coronaries with a lesser degree of proximal 
stenosis, an ITA to graft the right coronary artery, and a SV to graft the 
circumflex. Despite similar long-term graft patency in diabetic and non-diabetic 
patients, long-term survival was worse in those with diabetes.  
 
4.4. Findings Compared to Other Studies  
Studies differ regarding the effect of diabetes on bypass graft patency. 
Supporting our observations, Schwartz and colleagues [3] found similar graft 
patency in patients with and without diabetes using angiographic data from the 
original BARI trial. ITA graft patency was 89% in diabetic patients vs. 85% in non-
diabetic patients (P=.2), and SV graft patency was 71% vs. 75% (P=.4), 
respectively, at a mean follow-up of 3.9 years. Hwang and colleagues [4] found 
5-year arterial graft patency of 95% in diabetic and 91% in non-diabetic patients. 
In their study, early, 1-, and 5-year follow-up angiograms were performed 
independently of patients’ ischemic symptoms. Goldman and colleagues [8] 
studied long-term (10-year) patency of 457 ITA grafts and 1,074 SV grafts and 
identified risk factors for graft occlusion. Similar to our findings, they did not find 
diabetes to be a risk factor for graft occlusion.  
Contrary to our findings, Deb and colleagues [5] found greater SV graft 
occlusion in diabetics; 25% in diabetic and 16% in non-diabetic patients at least 5 
years after CABG (P=.06). Yilmaz and colleagues [7] also found diabetes to be 




colleagues [6] found similar arterial graft patency in matched diabetic and non-
diabetic patients, but worse SV graft patency in diabetic patients.  
 
4.5 Addition to Literature in Light of Systematic Review 
A systematic literature search was done to identify studies that already existed 
on this topic at the time of paper preparation/publication so that the addition to 
the literature that the study made could be effectively evaluated in the light of 
existing knowledge on the subject. The details of this systematic review are given 
in the Appendix (see section 10.3). Briefly, we searched the literature for studies 
reporting mid- to long-term (at least 5 years) angiographic outcomes of ITA and 
SV grafts in diabetic vs. non-diabetic patients. Studies reporting only short-term 
patency (<5 years), or studies reporting influence of diabetes on overall patency 
of bypass grafts and not individually for ITA and SV grafts were excluded. Only 
three studies were identified which met the specified criteria. These included 
studies by Schwartz et al [3], Hwang et al [4], and Deb et al [5] discussed in the 
preceding section. The studies by Schwartz and colleagues and Hwang and 
colleagues supported our findings whereas the results of the study by Deb and 
colleagues were contrary to our findings. The fact that we studied 20,066 SV 
grafts and 7,903 ITA grafts in a total of 11,519 patients distinguishes our study 
from theirs. The study by Schwartz et al studied only 1093 SV grafts and 551 ITA 
grafts. Hwang et al studied the patency of bypass grafts in only 558 patients and  
Deb et al studied the patency of bypass grafts in only 269 patients. Furthermore, 




al and Hwang et al reported patency for up to 5 years after CABG and Deb et al 
reported patency for up to about 10 years after CABG. Therefore, we believe that 
our study, by virtue of its large sample size, long follow-up, and distinctive 
statistical methodology, provides strong supporting evidence for our assertions 
and represents a valuable addition to the literature on this topic.  
 
4.6 Critical Commentary  
Help was taken from Critical Appraisal Skills Program (CASP) checklist for 




As mentioned in the introduction section of the paper, this study sought to 
answer a clearly focused question: Does diabetes influence long-term patency of 
coronary artery bypass grafts? The introduction section of the paper clearly 
presented the rationale of the study. Because diabetic patients represent an 
important and growing population of patients undergoing CABG and not much is 
known about the effect of diabetes on long-term graft patency, it is important to 
investigate the given research question. However, we could have also added that 
our previous study showed that long-term survival after CABG was worse in 
diabetic vs. non-diabetic patients and this could be due to worse long-term 






4.6.2 Study Design 
This was a retrospective observational study. An RCT was not possible to study 
this question, as patients cannot be randomized into diabetes and no-diabetes 
categories. However, a prospective study with routine angiography at specified 
intervals would be the best method for determining graft patency. Although in 
some prospective studies high proportions of patients have undergone early 
angiography, by 5 years, patient dropout due to death, reoperation, and refusal to 
participate altered the characteristics of the remaining population in nonrandom 
ways [11-14]. Therefore, it is not easy to study long-term (>20 years) 
angiographic outcomes of CABG prospectively with routine angiograms at 
regular intervals.   
 
4.6.3 Participant Selection 
 The cohort was recruited in an acceptable way. We used data from Cleveland 
Clinic’s Cardiovascular Information Registry (CVIR) and identified patients who 
underwent primary isolated CABG at the Cleveland Clinic from 1972 to 2011. 
Both, non-diabetic patients and diabetic patients were identified and extracted 
from the same registry i.e. CVIR.  
 Patients with unknown diabetic status were excluded. Patients were 
considered diabetic if they were medically treated for diabetes (taking insulin or 
medications for diabetes), as mentioned in the paper. All of the subjects were 
classified into exposure groups using the same definition. Because the primary 




patients having at least one post-operative angiogram prior to any repeat 
coronary intervention i.e. PCI or CABG, were included. Data on graft patency 
was obtained through diagnostic catheterization data available in the CVIR and 
PCI registry. Patients with post-operative angiogram after a repeat coronary 
intervention were excluded because repeat coronary intervention could have 
influenced the primary outcome, graft patency. Patients with unknown diabetic 
status were excluded because it was not possible to study the influence of 
diabetes on graft patency of such patients.  
 It was not mentioned in the paper whether this study required any 
additional data-collection, apart from the data retrieved from the registries. As 
mentioned in section 8.3, this study required data collection of missing diagnostic 
catheterizations. I did this data-collection myself.  
 
4.6.4 Sample Size 
A sample size calculation was not done. This was a retrospective cohort study of 
patients who underwent primary isolated CABG at the Cleveland Clinic during a 
given time period. Therefore, a sample size calculation would not have affected 
the number of patients included. However, given that we studied 7,903 ITA grafts 
and 20,066 SV grafts, our study was adequately powered to detect a difference, 
under the assumption that one exists. For example, we studied 1132 ITA grafts in 
diabetic patients and 6771 ITA grafts in non-diabetic patients. The 20-year ITA 
graft patency in both patient populations was above 90%. To detect a difference 




>99% powered, at a significance level of 5%. Please note that some criticize the 
idea of retrospective power calculation. However, it was done just to provide an 
approximate idea regarding the statistical power of the study.    
 
4.6.5 End-points 
The primary end-point of the study was graft patency. A graft was considered 
patent if not occluded. This was because grafts tended to be either completely 
open (0% stenosed) or occluded (100% stenosed), as shown in Figure 3 of the 
manuscript. Therefore, for analysis of this bimodal distribution, a graft was 
defined as patent if not occluded on follow-up angiography. The follow-up was 
long enough (20-year patency estimate provided in the paper). One of the 
limitations of the study was that our stenosis data (from angiograms read by 
expert cardiologists) were based on qualitative angiography and not quantitative 
angiography, so inter-observer and intra-observer variability cannot be ruled out. 
Although quantitative coronary angiography is more reproducible, it is time-
consuming and expensive. Given the number of patients in the study, 
retrospective quantitative analysis was not feasible. However, clinical decision-
making is virtually always based on qualitative and not quantitative angiography. 
Therefore, qualitative angiography represents the real-world approach.  
 Long-term mortality was also studied in diabetic vs. non-diabetic patients 
undergoing CABG. Although we knew from our previous study that long-term 
mortality was higher in diabetic patients undergoing CABG, it was important to 




angiography after CABG, presumed to be mainly due to ischemic symptoms. The 
median follow-up was provided for long-term mortality as distribution of survival 
data is usually (positively) skewed. Vital status was obtained by CVIR routine 
anniversary follow-up questionnaires supplemented with data from the Social 
Security Death Master File. Please see section 3.6.5 for in-depth critical 
commentary on our long-term mortality follow-up.  
 
4.6.6 Data Analysis  
Longitudinal Analysis: Because date of graft occlusion is rarely known, rendering 
time-to-event (Kaplan-Meier) analysis non-applicable, we used longitudinal data 
analysis to study bypass graft patency. The objective of this method was to 
estimate the ensemble average patency across time after CABG from multiple 
angiographic “snapshots” of the status of patients’ grafts, much as one would do 
for multiple blood pressure readings across time. 
 Marginal models and mixed effects models are two frequently used 
modeling approaches to analyze longitudinal data. A mixed effect modeling 
approach is preferable to a marginal modeling approach because, in practice, 
longitudinal data are often highly unbalanced in the sense that each subject has 
different number of longitudinal responses observed at non-fixed time points. In 
our study, the longitudinal binary measurement was unbalanced because the 
number and timing of binary measurements of graft occlusion could be different 
for different patients. Therefore, to account for the possible association between 




model. We knew from previous studies that the probability of patency may be 
nonlinear over time and that the influence of possible risk factors may also 
change over time. Therefore, a nonlinear multiphase logistic mixed-effects model 
[15] was used to resolve the number of time phases in the odds domain to form a 
temporal decomposition model and to estimate the shaping parameters at each 
phase.  
 
Confounding: To control for confounding, the multivariable model for graft 
occlusion was adjusted for a number of risk factors. The variables considered 
and the details of this analysis are provided in the paper. This model was further 
adjusted for propensity score (propensity of having diabetes). However, any 
patient factors not included in the propensity model, or in the multivariable model 
for graft occlusion, that importantly affect outcomes might have biased our 
findings. 
 
Applicability of Results to Other Patients: We did not know on a case-by-case 
basis the indication for postoperative angiography. We presumed it was most 
likely for recurrence of ischemic symptoms. Therefore, it could be argued that the 
results—that graft patency is similar among diabetic and non-diabetic patients—
are applicable only to patients with ischemic symptoms who undergo 
angiography and may not be generalizable to the entire CABG population. To 
account for this, we studied the influence of diabetes on patency of bypass grafts 




surgery. The results of this analysis were similar to the overall results of our 
study and showed that diabetes was not associated with lower bypass graft 
patency.  
 
Work-up Bias Evaluation: The possibility of work-up bias affecting estimates of 
graft patency cannot be ignored because diabetic patients tend to be clinically 
followed for their diabetes more closely than non-diabetic patients. Therefore, we 
assessed time to first post-CABG angiography and frequency of angiographic 
assessment as explained in the paper.  
 
Long-term Mortality: Survival was assessed nonparametrically using the Kaplan-
Meier method, and parametrically using a multiphase hazard model (please see 
section 2.6.6 above for details regarding this model). 
 
Influence of Cardiac Death on Patency: To explore the possible influence of 
cardiac death on longitudinal estimates of graft patency, we performed a pattern-
mixture sensitivity analysis to estimate patency trends separately for patients 
who experienced a cardiac death and patients who were alive at the time of 
follow-up closing date. This analysis demonstrated that cardiac death did not 
substantially alter the results presented. In particular, it does not suggest that 






4.6.7 Results & Discussion 
The major finding of this study was that diabetes was not associated with lower 
graft patency. Given the range of confidence intervals, the results look precise. 
 These results were debated in the light of similar and contrary findings 
from other studies in the Discussion section of the paper. The limitations were 
also mentioned under the discussion section in detail.  
 The conclusions of the study were supported by the data presented and 
mentioned the implications of the results for clinical practice that use of ITA grafts 
should be maximized in all patients undergoing CABG as they have excellent 
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Supplemental (Online-Only) Material 
 
Online Appendix 1: Variables Considered in Analyses 
Demographics 
Age* (y), sex*, race*, weight (kg), height (cm), weight/height ratio, body surface 
area (m2), body mass index* (kg•m-2) 
 
Symptoms and surgical priorities 
New York Heart Association functional class* (I-IV), emergency surgery* 
 
Cardiac comorbidity 
Prior myocardial infarction*, atrial fibrillation or flutter*, complete heart block or 
pacer*, heart failure*, ventricular arrhythmia, left ventricular dysfunction* (none, 
mild, mild to moderate, moderate, moderate to severe, severe) 
 
Noncardiac comorbidity 
Pharmacologically treated diabetes, peripheral arterial disease*, carotid disease*, 
hypertension*, chronic obstructive pulmonary disease*, history of smoking*, prior 
stroke, bilirubin (mg•dL-1), total cholesterol* (mg•dL-1), high-density lipoprotein 
cholesterol* (mg•dL-1), low-density lipoprotein cholesterol (mg•dL-1), triglycerides* 
(mg•dL-1), creatinine* (mg•dL-1), blood urea nitrogen* (mg•dL-1), hematocrit (%) 
 
Coronary anatomy 
Number of systems diseased* (≥50% stenosis), left main trunk (LMT) disease, 
any LMT disease, LMT disease* (≥70% stenosis), LMT disease* (≥50% 
stenosis), left anterior descending coronary artery (LAD) system disease, any 
LAD system disease, LAD system disease* (≥70% stenosis), LAD system 
disease* (≥50% stenosis), left circumflex (LCx) coronary artery system disease, 
any LCx system disease, LCx system disease* (≥70% stenosis), LCx system 




system disease, RCA system disease* (≥70% stenosis), RCA system disease* 
(≥50% stenosis), proximal stenosis in native coronary systems (%)  
 
CABG details† 
ITA graft, SV graft, graft to artery (LAD, LCx, RCA, diagonal), interaction: graft 
(ITA, SV) and diabetes status, interaction: graft (ITA, SV) and proximal stenosis 
in native coronary systems (%) 
 
Experience:   




* Variables used in the saturated model to calculate propensity scores. 
† CABG details are additionally considered in the multivariable longitudinal 
analysis.  
 
Online Appendix 2: Details of Statistical Analyses 
Patency Analysis  
To assess the temporal trend of prevalence of graft occlusion over time after CABG, all 
postoperative coronary angiograms obtained on each patient were analyzed longitudinally 
to estimate patient-specific temporal profiles, and from these the ensemble average. 
Because the number and timing of binary measurements of graft occlusion were different 
for different patients, the longitudinal binary measurement is unbalanced. Therefore, to 
account for the association between binary measurements in individual patients, we used 
a logistic mixed-effects model. We knew from previous studies that the probability of 




i.e., different risk factors at different time phases or the same risk factor with varying 
influence at different time phases. Therefore, a nonlinear multiphase logistic mixed-
effects model (1) was used to resolve the number of time phases in the odds domain to 
form a temporal decomposition model and to estimate the shaping parameters at each 
phase. SAS® PROC NLMIXED was used to implement the model for longitudinal 
binary measurements (2).  
Propensity Score Development 
Using multivariable logistic regression, we first identified preoperative variables (E-
Appendix 1) associated with being diabetic (parsimonious model, Table E9). This was 
augmented with other preoperative patient factors to form a semi-saturated propensity 
model, as indicated in Appendix E1A. A propensity score for each patient was calculated 
and forced into the final model for risk adjustment, even if not statistically significant.  
Risk-factor Analysis 
Because of the limited capability of PROC NLMIXED to explore multivariable relations, 
we initially screened the variables (E-Appendix 1) using ordinary multivariable logistic 
regression (PROC LOGISTIC) and a computer-intensive machine learning “bagging” 
method (3), with the assumption of independence of observations and with entry criteria 
(.07) and stay criteria (.05). This analysis was performed simply to identify possible 
candidates for our repeated measurements multivariable model. Having identified these 
candidate variables and their transformations, if any, they were entered one by one until 




Because diabetes and type of graft were the variables of interest, interaction (graft 
type x diabetes status) variables were kept in the model regardless of statistical 
significance. Note that the multivariable model was further adjusted for propensity score 
of having diabetes (described above), to adjust for a possible confounding effect.  
Evaluation of Possible Work-up Bias  
To assess for possible work-up bias, time to first angiography and number of 
angiograms performed per patient were compared between diabetic and non-
diabetic patients. This was done in three ways. First, median times to first 
angiography and median number of angiograms performed per patient for all 
diabetic and non-diabetic patients were compared. Second, these same statistics 
were compiled in the propensity-matched pairs and compared. For this, greedy 
matching based on the calculated propensity scores was used to match diabetic 
with non-diabetic patients, yielding 1,328 matched pairs (97% of possible 
matches). A mirrored histogram of distribution of propensity scores for diabetic 
and non-diabetic patients showed that the matched cohort covered the complete 
spectrum of cases, and the standardized difference plot demonstrated that 
covariable balance was achieved across nearly all variables (Figure E9). Finally, 
the hazard functions for first angiography for the matched diabetic and non-
diabetic patients were determined and compared. 
 To further investigate work-up bias, New York Heart Association functional 
class at first angiography was compared between diabetic and non-diabetic 
patients. Functional class at first angiography was available in 9,167 non-diabetic 




Long-term Survival Analysis  
Vital status after hospital discharge was obtained by routine anniversary follow-
up questionnaires and supplemented with data from the Social Security Death 
Master File, accessed on October 27, 2011, with a closing date of April 27, 2011. 
A total of 121,120 patient-years of follow-up data were available for analyses. 
Median follow-up was 10 years, with 25% of survivors followed for >18 years and 
10% for >25 years. For diabetic patients, 9,660 patient-years of follow-up data 
were available for analyses, with a median follow-up of 6.1 years; 25% of 
survivors were followed for >11 years and 10% for >17 years. For non-diabetic 
patients, 111,460 patient-years of follow-up data were available for analyses, 
with a median follow-up of 11 years; 25% of survivors were followed for >20 
years and 10% for >25 years.  
     For overall and matched patients, survival was assessed nonparametrically 
using the Kaplan-Meier method, and parametrically using a multiphase hazard 
model (6). The latter involved resolving the number of hazard phases for 
instantaneous risk of death (hazard function) and estimating shaping parameters. 
(For details, see www.lerner.ccf.org/qhs/software/hazard.)  
Pattern Mixture Analysis  
The nonlinear logistic mixed-effects model used in our analysis assumes there is 
no informative censoring. To assess for possible association between 
longitudinal binary occlusion data and cardiac death, and demonstrate that 
cardiac death is not informative of the longitudinal trend of graft patency, we 




patients who experienced cardiac death exhibited a different pattern of temporal 
trend of patency than the pattern in patients who were alive at the end of the 
study follow-up. This sensitivity analysis was repeated for subgroups of patients 
with and without diabetes receiving ITA grafts, and those receiving SV grafts. 
The proper statistical approach for this problem is to jointly model the longitudinal 
binary response and time-to-event cardiac death outcome. There are numerous 
models that jointly model continuous longitudinal outcome and time-to-event 
outcomes. However, because of computational difficulties arising from the 
nonlinear link functions and possible nonlinearity in the longitudinal trend, there 
are few, if any, methods that jointly model binary longitudinal outcome and time-
to-event outcome. Therefore, in the present state of lack of joint modeling 
methods for longitudinal binary data and time-to-event data, the pattern mixture 
approach to a sensitivity analysis was probably the best way to assess for 
possible association between longitudinal binary occlusion data and cardiac 
death.  
Missing Values 
For missing values we used multiple imputation (7) with the Markov chain Monte 
Carlo technique with the assumption of missing at random. We used 5-fold 
multiple imputation with PROC MI (SAS v9.1). In multivariable modeling, for each 
imputed complete dataset, we estimated the regression coefficients and their 
variance–covariance matrix. Then, following Rubin (7), we combined the 




Presentation   
Graphical presentation of graft patency results is for mean effects, after 
considering the two sources of within-patient variability. Graphical solutions of the 
longitudinal equation were risk adjusted by holding values for variables in the 
model constant, as described in figure legends.  
Continuous variables are summarized as mean ± standard deviation and 
as 15th, 50th (median), and 85th percentiles for skewed distributions; 
comparisons were made using the Wilcoxon rank-sum test. Categorical data are 
summarized as frequencies and percentages; comparisons were made using the 
chi-squared test or Fisher’s exact test when frequency was less than 5. 
Uncertainty is expressed by confidence limits (CLs). 
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No. (%) or 
Mean ± SD na 
No. (%) or 
Mean ± SD 
Demographics      
     Age (y) 1,372 59 ± 9.0 10,147 56 ± 9.0 <.0001 
     Female 1,372 373 (27) 10,147    1,310 (13) <.0001 
     Race      
 Black 1,291     76 (5.9)   9,148   163 (1.8) <.0001 
 White 1,291  1,166 (90)   9,148    8,757 (96) <.0001 
     Body mass index (kg•m
-2
)    890 30 ± 5.2   4,094 27 ± 4.0 <.0001 
Acuity      
     NYHA functional class 1,367  10,083    .07 
 I   200 (15)  1,382 (14)  
 II   469 (34)  3,454 (34)  
 III   164 (12)  1,022 (10)  
 IV   534 (39)  4,225 (42)  
     Emergency operation 1,372     14 (1.0) 10,146     134 (1.3)  
Native coronary artery 
 diseaseb      
     Left main trunk 1,317   172 (13)  10,024 1,162 (12)    .12 
     Left anterior descending 1,369 1,263 (92) 10,140 9,126 (90)    .008 
     Circumflex 1,360 1,084 (80) 10,110 6,801 (67) <.0001 
     Right coronary artery 1,365 1,161 (85) 10,112 8,018 (79)  <.0001 
     No. of coronary systems  
    diseased 1,372  10,147  <.0001 
 0
c
         4 (0.29)        56 (0.55)  
 1    103 (7.5)     1,417 (14)  
 2   390 (28)     3,494 (34)  
 3   875 (64)     5,180 (51)  
Cardiac comorbidity      





     Left ventricular dysfunction 1,294    <.0001 
 None     1,049 (81) 10,003 9,331 (93)  
 Mild       96 (7.4)     356 (3.6)  
 Mild to moderate      21 (1.6)        54 (0.54)  
 Moderate      78 (6.0)    177 (1.8)  
 Moderate to severe      27 (2.1)           42 (0.42)  
 Severe      23 (1.8)       43 (0.43)  
Noncardiac comorbidity      
     Peripheral arterial disease 1,372  183 (13) 10,147   748 (7.4) <.0001 
     Carotid disease 1,372  166 (12) 10,147   252 (2.5) <.0001 
     Hypertension    600  472 (79)   1,442  933 (65) <.0001 
     Smoking 1,351  634 (47)   9,884    5,213 (53) <.0001 
     Prior stroke 1,372     75 (5.5) 10,147   178 (1.8) <.0001 




    576 0.8/1.1/1.4   1,365     0.8/1.1/1.4   .7 
     Cholesterol (mg•dL
-1
)      
 Total     925   230 ± 56   7,619 248 ± 54 <.0001 
      HDL     470 36 ± 11   1,819   39 ± 12 <.0001 
      LDL     313   134 ± 46      827 142 ± 45   .003 
     Triglycerides (mg•dL
-1
)    805 226 ± 184   6,474   198 ± 117   .01 
a. Patients with data available.  
b. ≥50% stenosis. 
c.  These patients had left main trunk disease only. It was not anatomically coded as 
   multisystem disease. 
d. 15th/50th/85th percentiles. 
 
Key: HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; 





Online Table 2. Patient characteristics of angiographically studied (postoperative 





No Postop Cathb 
(n=43,982) 
nc 
No. (%) or 
Mean ± SD nc 
No. (%) or 
Mean ± SD 
Diabetes 11,519   43,892  
     Medically treated  1,372 (12)  8,973 (20) 
 Insulin     255 (19)  2,537 (28) 
 No insulin     344 (25)  3,483 (39) 
 Unknown     773 (56)  2,953 (33) 
Demographics     
     Age (y) 11,519 56 ± 9.0 43,982 61 ± 10 
     Female 11,519 1,683 (15) 43,982   8,943 (20) 
     White race 10,439 9,923 (95) 40,663 37,035 (91) 
     Body mass index (kg•m
-2
)   4,984 28 ± 4.4 27,719 28 ± 4.5 
Acuity     
     NYHA functional class 11,450  43,642  
 I  1,582 (14)    7,862 (18) 
 II  3,923 (34)  16,589 (38) 
 III  1,186 (10)    4,988 (11) 
 IV  4,759 (42)  14,203 (33) 
Native coronary artery 
 diseased     
     Left main trunk 11,341   1,334 (12) 39,845   7,119 (18) 
     Left anterior descending 11,509 10,389 (90) 41,404 38,315 (93) 
     Circumflex 11,470   7,885 (69) 41,094 30,140 (73) 
     Right coronary artery 11,477   9,179 (80) 41,140 33,862 (82) 
     Number of coronary    
     systems diseased 11,519  41,502  
 0         60 (0.52)         375 (0.90) 
 1    1,520 (13)    4,405 (11) 
 2    3,884 (34)  12,254 (30) 





Cardiac comorbidity     
     Prior MI 11,519 6,178 (54) 43,982 22,671 (52) 
     Heart failure 11,519     397 (3.4) 43,982    3,573 (8.1) 
Noncardiac comorbidity     
     Peripheral arterial disease 11,519     931 (8.1) 43,982   5,461 (12) 
     Carotid disease 11,519     418 (3.6) 43,982   5,294 (12) 
     Smoking 11,235 5,847 (52) 43,218 23,612 (55) 
     Prior stroke 11,519     253 (2.2) 43,982    2,142 (4.9) 
     Cholesterol (mg•dL
-1
)     
      Total    8,544 246 ± 54 34,114      226 ± 58 
      HDL    2,289   38 ± 12 17,728    40 ± 13 
      LDL   1,140 140 ± 45 12,785  122 ± 46 
     Triglycerides (mg•dL
-1
)   7,279   201 ± 127 28,641    186 ± 129 
     CABG details      
 ITA grafts at index  
     operation 11,519  43,982  
      0  4,468 (39)  12,438 (28) 
      1  6,256 (54)  26,474 (60) 
      2     795 (6.9)    5,070 (12) 
          Incomplete revasc.
d
  11,519 1,522 (13) 43,982    4,142 (9.4) 
     In-hospital outcomes 11,519  43,982  
      Death         5 (0.043)       772 (1.8) 
 Permanent stroke      68 (0.59)       805 (1.8) 
 Perioperative MI  382 (3.3)       774 (1.8) 
     Surgery date     
 1/1/1972 to index  
     operation (y)  11,519 10 ± 7.7  43,982 17 ± 10  
Note: All P-values <.0001. 
a. Study cohort. 
b. Not in study. 
c. Patients with data available. 
d. ≥50% stenosis. 
Key: CABG, coronary artery bypass grafting; HDL, high-density lipoprotein; ITA, internal 
thoracic artery; LDL, low-density lipoprotein; MI, myocardial infarction; NYHA, New York 

















  6,951 
 
 8,124 
     LAD    938   5,452  6,390 
     Diagonal    118      623     741 
     LCx        98      666     764 
     RCA        19      210     229 
 







     LAD    309   3,309   3,618 
     Diagonal    401   2,442   2,843 
     LCx      959   6,182   7,141 
     RCA      904   5,870   6,774 
 
Other conduit to: 
 
  135 
 
   241 
 
    376 
     LAD      4      10       14 
     Diagonal    19      51       70 
     LCx      85    113     198 
     RCA      27      67       94 
 
 
Key: ITA, internal thoracic artery; LAD, left anterior descending coronary artery; LCx, left 










Online Table 4. Number of postoperative angiographic studies by conduit type 
















     LAD 1,183  7,421   8,604 
     Diagonal    137     800      937 
     LCx      130     872   1,002 
     RCA        23     268      291 
 







     LAD    379   4,466   4,845 
     Diagonal    516   3,281   3,797 
     LCx   1,216   8,359   9,575 
     RCA   1,144   7,995   9,139 
 




    388 
 
 563 
     LAD      24       62        86 
     Diagonal      33       85      118 
     LCx        86     153      239 
     RCA        32       88      120 
 
 
Key: ITA, internal thoracic artery; LAD, left anterior descending coronary artery; LCx, left 
circumflex coronary artery; RCA, right coronary artery. 




      Online Table 5. Risk factors for graft occlusion 
 
Factor Estimate ± SE P 
Early constant phase   
     Female 0.32 ± 0.075   <.0001 
     Graft to LAD   
            ITA  -0.75 ± 0.18   <.0001 
            SV    -0.62 ± 0.087   <.0001 
     Graft to RCA   
           ITA    1.2 ± 0.24   <.0001 
           SV (no effect) -0.032 ± 0.061     .6 
     Preoperative stenosis and graft   
           Lower stenosis and ITA   -1.2 ± 0.15   <.0001 
           Stenosis and SV (no effect)  0.0093 ± 0.085     .9 
     Diabetes and graft type  
         (compared with no diabetes and ITA) 
 
 
            Diabetes and ITA -0.47 ± 0.19     .013 
            No diabetes and SV
a
 -0.44 ± 0.26     .09 
            Diabetes and SV
a
 -0.45 ± 0.27     .103 
    Propensity score
b
    0.12 ± 0.024   <.0001 
Late increasing phase   
     Younger age
c
   -2.2 ± 0.23   <.0001 
     NYHA functional class I  0.21 ± 0.096     .03 
     Higher triglycerides
d
  0.26 ± 0.102     .04 
     Graft to LAD   
          ITA -1.2 ± 1.1     .3 
          SV   -0.86 ± 0.099   <.0001 
     Graft to circumflex   
         ITA   1.6 ± 0.87     .06 
         SV   0.22 ± 0.062     .0004 
     Diabetes and graft type (compared with no 
  diabetes and ITA) 
 
 
           Diabetes and ITA   -0.24 ± 0.98     .8 
           No diabetes and SV
a




           Diabetes and SV
a
  3.4 ± 0.90     .0001 
    Propensity score
b
 -0.036 ± 0.038     .3 
 
 
a. Early and late patency was similar for SV grafts between diabetics and non-diabetics 
(early P=.9, late P=.8).  
b. Log(propensity score/[1-propensity]), logistic transformation. 
c. Log(age), logarithmic transformation. 
d. Log(triglycerides), logarithmic transformation. 
 
Key: ITA, internal thoracic artery; LAD, left anterior descending coronary artery; NYHA, 


































Online Table 6. Observed vs. predicted number of occluded grafts for patients 








Occlusion  P 
Non-diabetic 
patients 
    
     All 1,768 199 201        .9 
     ITA grafts    406   13   16        .4 
     SV grafts 1,362 186 185      >.9 
Diabetic patients     
     All    115   18   20        .6 
     ITA grafts      27    1     2        .3 
     SV grafts      88   17   18        .8 
  
 






Online Table 7. Time to first coronary angiography and number of angiograms per patient, stratified by diabetes 
 
Variable 
No Diabetes Diabetes 





Unadjusted       
     Time to first angiogram 10,147 0.96/4.0/11 1,372 0.95/3.4/8.4  <.0001   .0009 
     No. of angiograms per patient 10,147 2/3/5 1,372 2/3/5  <.0001 <.0001 
 1   1,245 12%      96 7.0%   
 2   3,063 30%    324 24%   
 3   2,583 25%    459 33%   
 4   1,630 16%    273 20%   
 5      106       1.0%      26      1.9%   
 6      827       8.1%      99      7.2%   
          ≥7      693       7.8%      95      7.0%   
Propensity matched       
     Time to first angiogram 1,328 0.70/4.2/9.6 1,328 0.94/3.4/8.4   .003   .005 
     No. of angiograms per patient 1,328 2/3/6 1,328 2/3/5   .004   .006 
 1      65     4.9%      94      7.1%   
 2    282 21%    319 24%   
 3    448 34%    438 33%   




 5   24    1.8%    26    2.0%   
 6   93    7.0%    95    7.2%   
          ≥7 110    8.3%    92    6.9%   
 
 
a. Wilcoxon rank-sum test. 
 







Online Table 8. Postoperative NYHA functional class at first coronary 
angiography, stratified by diabetes  
 
Variable 
Diabetes No Diabetes 
P na No. (%) na No. (%) 
Unmatched      
     NYHA functional class 1,137  9,167    <.0001 
 I  412 (36)  4,140 (45)  
 II  335 (29)  2,394 (26)  
 III   113 (9.9)      600 (6.5)  
 IV  277 (24)  2,033 (22)  
Matched      
     NYHA functional class 1,104  1,068      .14 
 I  400 (36)      338 (32)  
 II  329 (30)      351 (33)  
 III  109 (9.9)      113 (11)  
 IV  266 (24)      266 (25)  
 
 

















  Online Table 9. Factors associated with being diabetic 
 
Variable Estimate ± SE P Reliability (%)a 
Demographics    
     Female      0.82 ± 0.075 <.0001          100 
     Black or other race (vs. white)      0.75 ± 0.13 <.0001 56 
Cardiac comorbidity    
     Heart failure      0.60 ± 0.13 <.0001 77 
     Coronary system diseaseb    
      LCx 0.49 ± 0.067 <.0001 74 
      RCA 0.22 ± 0.073 .003 68 
     Lower or higher LV function 0.31 ± 0.032 <.0001 86 
Noncardiac comorbidity    
     Peripheral arterial disease 0.42 ± 0.098 <.0001 96 
     Carotid disease      1.03 ± 0.12 <.0001 62 
     Smoking     -0.34 ± 0.062 <.0001 95 
     Higher triglycerides 0.0024 ± 0.00031 <.0001 98 
     Lower total cholesterolc 0.45 ± 0.070  97 
Intercept     -2.19 ± 0.20 <.0001  
 
Note:  C-statistic=0.73. 
 
 
a. Percent of times factor appeared in 500 bootstrap models. 
 
b. ≥70% stenosis. 
 


















Online Figure 1. Number of internal thoracic artery (ITA) and saphenous vein 
(SV) bypass grafts studied by angiography each year after coronary artery 
bypass grafting (CABG). Note logarithmic vertical axis. 
 





Online Figure 1. Number of internal thoracic artery (ITA) and saphenous vein 
(SV) bypass grafts studied by angiography each year after coronary artery 
bypass grafting (CABG). Note logarithmic vertical axis. 
 





Online Figure 1. Number of internal thoracic artery (ITA) and saphenous vein 
(SV) bypass grafts studied by angiography each year after coronary artery 
bypass grafting (CABG). Note logarithmic vertical axis. 
 










Online Figure 2. Number of patients and bypass grafts studied and 
postoperative angiograms available at and beyond each time point. Darker 










Online Figure 2. Number of patients and bypass grafts studied and 
postoperative angiograms available at and beyond each time point. Darker 
shaded portions represent diabetic patients. Key: Angios, angiograms.   
 








Online Figure 2. Number of patients and bypass grafts studied and 
postoperative angiograms available at and beyond each time point. Darker 
shaded portions represent diabetic patients. Key: Angios, angiograms.   
 










Online Figure 3. Quality of propensity matching of patients with and without 
diabetes.  
 
A, Mirrored histogram of distribution of propensity scores between groups. 








Online Figure 3. Quality of propensity matching of patients with and without 
diabetes.  
 
B, Covariate balance plot before and after propensity-score matching on 
selected covariables. Key: BMI, body mass index LVF, left ventricular function, 
Sys., systems; PAD, peripheral arterial disease; BSA, body surface area; MI, 






Online Figure 4. Temporal pattern of patency by decade of surgery.  
 




Online Figure 4. Temporal pattern of patency by decade of surgery. 
 












Online Figure 5. Nomograms of multivariable equation found in Table E5 
depicting temporal pattern of risk-adjusted patency of internal thoracic artery 
(ITA) and saphenous vein (SV) grafts in diabetic and non-diabetic patients. Solid 
lines are parametric estimates of prevalence based on average of patient-
specific profiles. 
A, Grafts to left anterior descending (LAD) coronary artery. Except for the 
variables depicted in the figure, all other variables are fixed as follows: male, 
New York Heart Association functional class I, graft to LAD, propensity of having 





Online Figure 5. Nomograms of multivariable equation found in Table E5 
depicting temporal pattern of risk-adjusted patency of internal thoracic artery 
(ITA) and saphenous vein (SV) grafts in diabetic and non-diabetic patients. Solid 
lines are parametric estimates of prevalence based on average of patient-
specific profiles. 
 
B, Grafts to circumflex coronary artery. Except for the variables depicted in the 
figure, all other variables are fixed as follows: male, New York Heart Association 
functional class I, graft to left circumflex coronary artery, propensity of having 





Online Figure 5. Nomograms of multivariable equation found in Table E5 
depicting temporal pattern of risk-adjusted patency of internal thoracic artery 
(ITA) and saphenous vein (SV) grafts in diabetic and non-diabetic patients. Solid 
lines are parametric estimates of prevalence based on average of patient-
specific profiles. 
 
C, Grafts to diagonal coronary artery. Except for the variables depicted in the 
figure, all other variables are fixed as follows: male, New York Heart Association 
functional class I, graft to diagonal, propensity of having diabetes=.5, proximal 






Online Figure 5. Nomograms of multivariable equation found in Table E5 
depicting temporal pattern of risk-adjusted patency of internal thoracic artery 
(ITA) and saphenous vein (SV) grafts in diabetic and non-diabetic patients. Solid 
lines are parametric estimates of prevalence based on average of patient-
specific profiles. 
 
D, Grafts to right coronary artery. Except for the variables depicted in the figure, 
all other variables are fixed as follows: male, New York Heart Association class I, 
graft to right coronary artery, propensity of having diabetes=.5, proximal 








Online Figure 6. Instantaneous risk of first coronary angiography after coronary 
artery bypass grafting (CABG) in diabetic and non-diabetic groups. Solid lines 
represent parametric estimates enclosed within a 68% confidence interval, 
equivalent to ±1 standard error. 






Online Figure 6. Instantaneous risk of first coronary angiography after coronary 
artery bypass grafting (CABG) in diabetic and non-diabetic groups. Solid lines 
represent parametric estimates enclosed with a 68% confidence interval, 
equivalent to ±1 standard error. 













Online Figure 7. Time-related death after primary isolated coronary artery 
bypass grafting in diabetic and non-diabetic patients. Solid lines are parametric 
estimates enclosed within a dashed 68% confidence interval equivalent to ±1 
standard error. Each symbol represents a death; vertical bars are confidence 
limits equivalent to ±1 standard error. 
 






Online Figure 7. Time-related death after primary isolated coronary artery 
bypass grafting in diabetic and non-diabetic patients. Solid lines are parametric 
estimates enclosed within a dashed 68% confidence interval equivalent to ±1 
standard error. Each symbol represents a death; vertical bars are confidence 
limits equivalent to ±1 standard error. 
 










Online Figure 7. Time-related death after primary isolated coronary artery 
bypass grafting in diabetic and non-diabetic patients. Solid lines are parametric 
estimates enclosed within a dashed 68% confidence interval equivalent to ±1 
standard error. Each symbol represents a death; vertical bars are confidence 
limits equivalent to ±1 standard error. 
 
 







Online Figure 7. Time-related death after primary isolated coronary artery 
bypass grafting in diabetic and non-diabetic patients. Solid lines are parametric 
estimates enclosed within a dashed 68% confidence interval equivalent to ±1 
standard error. Each symbol represents a death; vertical bars are confidence 
limits equivalent to ±1 standard error. 
 
 








Online Figure 8. Patterns of temporal trend of patency stratified by alive versus 
death due to cardiac causes. Key: CABG, coronary artery bypass grafting. 
 

















Online Figure 8. Patterns of temporal trend of patency stratified by alive versus 
death due to cardiac causes. Key: CABG, coronary artery bypass grafting. 
 
 









Research Question 4—Which Surgical Techniques Improve Outcomes of 
CABG in Diabetic Patients? 
 
Based on Publication: Raza S, Sabik JF 3rd, Masabni K, Ainkaran P, Lytle BW, 
Blackstone EH. Surgical Revascularization Techniques that Minimize 
Surgical Risk and Maximize Late Survival After Coronary Artery Bypass 




The FREEDOM trial (Future Revascularization Evaluation in patients with 
Diabetes mellitus: Optimal Management of multivessel disease) showed that 
coronary artery bypass grafting (CABG) should be the preferred 
revascularization strategy for diabetics with multivessel coronary artery disease 
(CAD) [1]. This made it imperative to identify surgical techniques that optimize 
the outcomes of CABG in these patients. Our previous study (presented in 
Chapter 3) showed that diabetics make up nearly 40% of all patients undergoing 
surgical revascularization and represent an important & growing population of 
patients undergoing CABG today [2]. Therefore, the fourth research question 
that we sought to answer was: Which surgical techniques improve the outcomes 
of CABG in diabetic patients? In this regard, we evaluated the comparative 
effectiveness of (i) single internal thoracic artery (SITA) vs. bilateral internal 
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thoracic artery (BITA) grafting, (ii) complete vs. incomplete revascularization, 
and (iii) off-pump vs. on-pump CABG in diabetic patients undergoing CABG.   
 
5.2 Summary of Study Design & Method 
The study was based on 11,922 diabetic patients who underwent primary 
isolated CABG from January 1972 to January 2011, at the Cleveland Clinic. The 
type of diabetes management was known for 8,196 patients—2,743 insulin-
treated diabetics, 3,766 non–insulin-treated diabetics, and 1,687 diet-
controlled diabetics. The surgical revascularization techniques investigated 
included (i) SITA (n=8,466; 71%) and BITA (n=938; 7.9%) grafting with or 
without other grafts vs. saphenous vein grafting (SVG) alone (n=2,491; 21%), (ii) 
incomplete (n=2,109; 18%) vs. complete revascularization, and (iii) off- (n=602; 
5.0%) vs. on-pump CABG. The end-points studied included hospital outcomes 
and long-term mortality. Multivariable analyses were performed to assess the 
effects of surgical techniques on outcomes. To identify the patients deriving the 
greatest survival benefit from an optimal surgical technique, the multivariable 
hazard model was solved for each patient in the study to produce 10-year 
predicted survival based on 12 possible surgical combinations (derived from 0 
ITA, 1 ITA, 2 ITAs, incomplete revascularization, complete revascularization, off-






5.3 Summary of Results 
We found that BITA grafting was associated with 21% (68% CL, 16%-26%) and 
33% (68% CL, 28%- 37%) lower long-term mortality compared to SITA grafting 
and saphenous vein grafting, respectively. However, BITA grafting was also 
associated with higher risk of deep sternal wound infections (DSWI) when 
compared to SITA grafting. We identified obese diabetic females with diffuse 
atherosclerotic burden as the patient population that is at the highest risk of 
developing sternal wound infections (see Figure 2 of manuscript). Complete vs. 
incomplete revascularization had similar hospital outcomes but incomplete 
revascularization was associated with 10% (68% CL, 6%-13%) higher long-term 
mortality. Off-pump vs. on-pump surgery had similar hospital outcomes and 
long-term mortality. We also found that the combination of BITA grafting with 
complete revascularization using off-pump technique was associated with the 
best long-term survival (see Figure 4 of manuscript). This survival benefit was 
mainly driven by BITA grafting followed by complete revascularization.  
 
5.4 Findings Compared to Other Studies 
Other studies support our findings of BITA vs. SITA comparison in diabetic 
patients. Studies by Lytle et al [3], Dorman et al [4], and Steven et al [5] showed 
that BITA grafting improves long-term survival in diabetic patients undergoing 
CABG. The study by Endo et al [6] showed that BIMA grafts are beneficial in 
coronary revascularization for diabetic patients with preserved ejection fraction, 
 
 172 
but have limited survival benefit for those with reduced ejection fraction 
attributable to high cardiac mortality.  
 Despite evidence showing the association of BITA with better long-term 
survival, BITA grafting was performed in only 4.4% of CABG cases in the 
STS national database in 2011 [7,8]. This may be due to the fear of increased 
risk of DWSI [8,9], a trade-off with the long-term survival benefit. This increased 
risk is of particular concern in diabetics, because they are already at higher risk 
than non-diabetics of developing surgical site infections. Our data confirms this 
finding. However, we found that DSWI after BITA or SITA grafting minimally 
affected survival because of its rare occurrence. We identified women with large 
BMI, PAD, prior MI, and pharmacologically treated diabetes as patient 
characteristics associated with the highest risk of developing DSWI. In addition, 
we found that some of the risk factors associated with the greatest risk 
of developing DSWI after BITA grafting are also associated with deriving the 
greatest survival benefit from it. Thus, avoiding BITA grafting in patients at high 
risk for developing DSWI could lead to a decrease in the overall occurrence of 
DSWI at the expense of losing the long-term survival benefit gained from BITA 
grafting.   
 Recently, the results of the Arterial Revascularization Trial (ART) [10] 
were published in the New England Journal of Medicine (NEJM), and they 
showed no survival benefit of BITA grafts over SITA grafts at 10 years after 
surgery. I believe this trial failed to show the survival benefit of BITA grafts 
because of the following reasons. First, patients deriving the maximum survival 
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benefit from BITA grafting are sicker whereas ART-trial patients were relatively 
healthier. Second, the trial’s statistical power to detect a 5% difference in 10-
year survival between BITA vs. SITA patients had already been lowered by 45% 
because 16% of patients in BITA group didn’t actually receive BITA grafts (with 
power lowered further by 5% lost to follow-up at 5 years), so it was expected 
that the trial might not be able to detect a difference in survival at 10 years, 
assuming one exists. Third, the observational data shows that the incremental 
survival benefit of BITA grafting over SITA grafting becomes evident in the 
second decade after surgery. The ART trial only followed patients up until 10 
years after surgery. I wrote a letter-to-the-editor on the paper that presented 
five-year results of ART trial. The letter highlighted the important points 
mentioned here and was published by NEJM [11].  
 Early studies of CABG highlighted the survival advantage of 
complete over incomplete revascularization [12-14]. Since then, a number of 
studies have evaluated this effect, but literature specifically focusing 
on diabetics is sparse. Also, the definition of complete and incomplete 
revascularization has remained controversial, with different studies 
reporting different definitions [15]. We found that incomplete revascularization 
was associated with a higher risk of late death, highlighting the importance of 
completeness of revascularization for long-term survival benefit. Post-hoc 
analysis from the BARI 2D trial (Bypass Angioplasty Revascularization 
Investigation) also showed that less complete revascularization was associated 
with a higher risk of long-term cardiovascular events in diabetics [16].  
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 Although a number of studies have compared the outcomes of off- vs. on-
pump CABG [17-24], few have done so in diabetics [25-28]. Available studies 
show that in diabetic patients, off-pump CABG results in lower in-hospital 
morbidity and mortality and higher 1-year survival [25-27]. We found a small late 
survival benefit of off-pump CABG, similar in magnitude to complete vs. 
incomplete revascularization; however, the benefit could be due to chance, 
perhaps because of relatively small numbers. Both on- and off-pump strategies 
represent 2 skill sets which surgeons can use selectively. This is particularly 
relevant for patients at higher risk of developing complications from 
cardiopulmonary bypass or aortic manipulation, because they benefit the most 
from off-pump surgery.  
 
5.5 Addition to Literature in Light of Systematic Review 
A systematic literature search was done to identify studies that already existed 
on this topic at the time of paper preparation/publication so that the addition to 
the literature that the study made could be effectively evaluated in the light of 
existing knowledge on the subject. Details of this systematic review are given in 
the Appendix (see section 10.4). Briefly, we searched the literature for studies 
reporting the comparative effectiveness of (1) SITA versus BITA grafting, (2) 
complete versus incomplete revascularization, and (3) off-pump versus on-pump 
CABG in terms of long-term survival in diabetic patients undergoing CABG. 
Studies reporting the long-term survival (at least 10 years) with or without early 
outcomes of studied surgical techniques specifically in diabetic patients were 
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included. Studies reporting less than 10-year long-term survival were excluded. 
Four studies reporting the outcomes of BITA vs. SITA in diabetic patients [3-6] 
were found that met the specified inclusion criteria. One study reporting the 
outcomes of off-pump vs. on-pump surgery was found that met the inclusion 
criteria [29]. Regarding complete vs. incomplete revascularization in diabetic 
patients undergoing CABG, the search didn’t yield any studies meeting the 
specified criteria.  
 Of the 4 studies reporting outcomes of BITA vs. SITA in diabetic patients, 
three [3-5] showed that BITA grafting improves long-term survival in diabetic 
patients undergoing CABG, similar to the results of our study. The study by 
Endo et al [6] showed that BIMA grafts are beneficial in coronary 
revascularization for diabetic patients with preserved ejection fraction but have 
limited survival benefit for those with reduced ejection fraction attributable to 
high cardiac mortality. In these 4 studies the number of patients receiving BITA 
grafts ranged from 190 to 461, and the number of patients receiving SITA graft 
ranged from 277 to 646, whereas we studied the outcomes of 938 patients 
receiving BITA grafts and 8466 patients receiving SITA grafts.  
 One study reporting the outcomes of off-pump vs. on-pump surgery by 
Hemo et al [29] showed that off-pump CABG was associated with better long-
term survival than on-pump CABG in diabetic patients. However, this study only 
included patients receiving BITA grafts so the results are not generalizable to 
the vast majority of diabetic patients undergoing CABG who receive single ITA 
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grafts only. Moreover, this study included only 232 off-pump cases whereas we 
studied the outcomes of 602 off-pump CABG cases.   
 Though there were some studies available comparing long-term survival 
after CABG with BITA vs. SITA in diabetic patients, there was a dearth of 
studies comparing long-term outcomes of off-pump vs. on-pump surgery and 
complete vs. incomplete revascularization in diabetic patients undergoing 
CABG. Our study, therefore, added valuable evidence in these areas.   
 
5.6 Critical Commentary 
Help was taken from Critical Appraisal Skills Program (CASP) checklist for 
Cohort Studies for critical commentary on this manuscript. Available at: 
http://www.casp-uk.net/casp-tools-checklists. 
 
5.6.1 Rationale  
This study addresses a clearly focused issue of identifying surgical techniques 
that minimize the surgical risk and maximize the long-term survival after CABG 
in diabetic patients. Our previous study showed that the proportion of patients 
undergoing CABG who have diabetes increased from 7% in 1970s to about 40% 
in 2010 [2]. In 2012, the results of the landmark FREEDOM trial established 
CABG as the revascularization strategy of choice for diabetic patients with 
multivessel CAD [1]. These made it imperative to identify the techniques that 




5.6.2 Study Design  
This was a retrospective cohort study. RCTs comparing the long-term outcomes 
of patients undergoing CABG with different surgical techniques like BITA vs. 
SITA grafting, and off- vs. on-pump CABG would have been ideal. However, 
demonstrating the survival benefit of surgical techniques like BITA grafting 
needs long-term follow-up (ideally greater than 10 years). This is because the 
observational data show that the survival benefit of the BITA grafting becomes 
evident in the second decade after CABG. Conducting an RCT with a follow-up 
of more than 10 years is challenging. Therefore, studying this research question 
in a retrospective fashion is reasonable, as an RCT with 15-20 years of follow-
up would be expensive and challenging.  
 
5.6.3 Participant Selection  
The cohort was recruited in an acceptable way. Cleveland Clinic’s 
Cardiovascular Information Registry (CVIR) was used to identify all diabetic 
patients who underwent primary isolated CABG at the Cleveland Clinic from 
1972 through 2011. Of the 11,922 diabetic patients identified, diabetes 
management status was known for 8196 patients—2743 insulin-treated, 3766 
non–insulin-treated, and 1687 diet-controlled. However, we were unable to 
discriminate between type I and type II diabetes. This maybe important as the 
long-term survival after CABG in type 1 diabetic patients is worse than the 
survival in type II diabetic patients. However, this was not mentioned in the 
imitations section of the paper.  
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 The three main comparisons of interest in our study included (i) BITA vs. 
SITA grafting, (ii) complete vs. incomplete revascularization, and (iii) off- vs. on-
pump CABG. Patients were reliably classified into respective groups as these 
details are clearly mentioned in operative reports.  
 It was not mentioned in the paper whether this study required any 
additional data-collection, apart from the data retrieved from CVIR. No additional 
data was collected for this study.  
 
5.6.4 Sample Size  
Our study showed that the 20-year survival after CABG in diabetic patients was 
21% with SITA grafting and 37% with BITA grafting. To detect this difference, 
our study was 100% powered, at a significance level of 5%. The 20-year 
survival after CABG in diabetic patients was 18% with incomplete 
revascularization and 21% with complete revascularization. To detect this 
difference, our study was 88% powered, at a significance level of 5%. The 10-
year survival after CABG in diabetic patients was 56% with off-pump surgery 
and 56% with on-pump surgery (a 20-year estimate was not available for this 
comparison). To detect a difference of 5% in survival between off-pump vs. on-
pump CABG, assuming one existed, our study was only 68% powered, at a 
significance level of 5%. However, to detect a difference of 10%, assuming one 
existed, our study was >99% powered. Please note that some criticize the idea 
of retrospective power calculation. However, it was done to provide an 
approximate idea regarding statistical power of the study.  
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 BITA grafting, incomplete revascularization, and off-pump CABG all 
represented small subsets of our study, which might have limited our ability to 
identify small incremental benefits within the 12 combinations of surgical 
strategies analyzed.  
 
5.6.5 End-points 
The end-points of the study included hospital outcomes and long-term mortality. 
Please see 3.6.5 for in-depth critical commentary on our long-term mortality 
follow-up.  
 
5.6.6 Data Analysis  
We used multivariate analyses for risk adjustment. A number of variables 
(detailed in the appendix of the paper) were considered in this analysis ranging 
from demographic variables, to cardiac and non-cardiac comorbidities, and date 
of operation. However, any patient factors not included in the propensity model 
that importantly affect outcomes may have biased our findings.  
 Alternatively, propensity matching could have been used for risk-
adjustment. However, this would have required several separate propensity 
analyses to compare saphenous vein grafting vs. SITA grafting vs. BITA 
grafting, complete vs. incomplete revascularization, and off- vs. on-pump CABG. 
We used multivariable risk-adjustment because it is not realistic to see these 
surgical techniques in isolation of each other, as any single CABG procedure is 
actually a combination of these techniques. Moreover, of the 12 possible 
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realistic combinations of these 7 surgical techniques, multivariable analysis 
allowed us to identify the combination with best long-term survival.  
 Survival was assessed nonparametrically using the Kaplan-Meier 
method, and parametrically using a multiphase hazard model. Please see 
section 2.6.6 above for details regarding this model, and also for explanation 
regarding the use of 68% confidence interval in the paper.   
 
5.6.7 Results & Discussion 
The study showed that BITA versus SITA grafting was associated with 21% 
(68% CL, 16%-26%) lower late mortality in patients with multivessel disease. 
Incomplete revascularization was associated with 10% higher (68% CL, 6%-
13%) late mortality. Off- pump CABG was associated with 10% lower late 
mortality than on-pump CABG, but the difference was not statistically significant.  
 Survival was reported for up to 20 years. The results look precise given 
the range of the confidence intervals provided in the results and figures of the 
manuscript. The results are believable because the study compared outcomes 
in a large number of patients using data from a well-regarded registry and took 
appropriate measures to control for confounding.  
 The discussion section clearly mentioned the principal findings of the 
study, and in the section of “findings in context”, we discussed the existing 




 The discussion section also mentioned the limitations of the paper, which 
included that fact that this was a single center study and findings may not be 
generalizable. Nevertheless, with the increasing proportion of patients with 
diabetes undergoing CABG, and the widespread experience with the use of ITA 
grafting and off-pump surgery, our experience should be repeatable in other 
centers that see diabetic patients in need of CABG. 
 The conclusions of the paper were supported by the data presented and 
mentioned the clinical implications of the study instead of just summarizing the 
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Research Question 5—Which Arterial Grafting Strategy Improves 
Outcomes of CABG in Diabetic Patients? 
 
Based on Publication: Raza S, Blackstone EH, Houghtaling PL, Koprivanac M, 
Ravichandren K, Javadikasgari H, Bakaeen FG, Svensson LG, Sabik JF 3rd. 
Similar Outcomes in Diabetic Patients After CABG With Single ITA Plus 




6.1 Rationale  
We showed in the previous study (chapter 5) that bilateral internal thoracic 
artery (BITA) grafting with complete revascularization maximizes long-term 
survival in diabetic patients undergoing CABG, and that off-pump or on-pump 
surgery can be used with equal effectiveness [1]. However, because BITA 
grafting, compared to single internal thoracic artery (SITA) grafting, was also 
associated with increased risk of deep sternal wound infections (DSWI), we 
recommended that it be used in diabetic patients whose risk of DSWI is low. The 
radial artery (RA) is another commonly used arterial graft conduit that has been 
shown to be associated with better clinical and angiographic outcomes than vein 
grafts [2,3]. Therefore, we sought to determine whether SITA+RA grafting yields 
outcomes similar to those of BITA grafting in diabetic patients. We hypothesized 
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that SITA+RA grafting would be associated with a lower occurrence of DSWI 
and similar long-term survival compared with BITA grafting in diabetic patients 
undergoing CABG.  
 
6.2 Summary of Study Design & Methods  
From January 1994 to January 2011, 1,325 diabetic patients with multisystem 
coronary artery disease (CAD) underwent primary isolated CABG with either (i) 
SITA plus RA with or without saphenous vein grafts (hereafter referred to as 
SITA+RA; n=965) or (ii) BITA with or without saphenous vein grafts (hereafter 
referred to as BITA; n=360). An internal thoracic artery was used in all patients 
to graft the left anterior descending coronary artery. The majority (88%) of 
coronary arteries with ≥50% stenosis that were grafted by either a radial artery 
or a second ITA were severely stenosed (≥70%); only 12% were moderately 
stenosed. 
 The endpoints were in-hospital outcomes and time-related mortality. The 
median follow-up was 7.4 years, with a total follow-up of 9,162 patient-years. 
Propensity-score matching was performed to identify 282 well-matched pairs for 
adjusted comparisons.  
 
6.3 Summary of Results 
The unadjusted in-hospital mortality was 0.52% for SITA+RA and 0.28% for 
BITA grafts, and the prevalence of DSWI was 3.2% and 1.7%, respectively. In 
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propensity-matched pairs, all hospital outcomes and lengths of stay were similar 
in the 2 groups.  
 The unadjusted survival at 1, 5, 10, and 14 years was 97%, 88%, 68% 
and 51% for the SITA+RA group and 97%, 95%, 80%, and 66% for the BITA 
group (see Figure 1A of manuscript). The instantaneous risk of death was 
substantially elevated early after surgery and then gradually decreased over the 
first 6 months for both groups. Thereafter, the risk of death gradually increased 
over time for both (see Figure 1B of manuscript).  
In the propensity-matched patients, the survival was similar for the 2 
groups: at 1, 5, 10, and 14 years, it was 97%, 90%, 70%, and 58% for the 
SITA+RA group and 97%, 93%, 79%, and 64% for the BITA group, respectively 
(early P=.8, late P=.2; see Figure 2A of manuscript). The instantaneous risk of 
death was substantially elevated early after surgery for both groups and 
gradually decreased during the first 6 months for SITA+RA patients and the first 
12 months for BITA patients. Thereafter, the risk of death gradually increased 
over time, similarly for both groups (see Figure 2B of manuscript). 
 
6.4 Findings Compared to Other Studies  
A number of studies are available comparing the outcomes of SITA+RA vs. 
BITA grafting in patients undergoing CABG [4], but data regarding use of 
SITA+RA vs. BITA grafting specifically in diabetic patients are scarce [5,6]. 
Supporting our findings, a study by Hoffman et al [5] showed that among 202 
matched pairs from each group, diabetic and non-diabetic patients, undergoing 
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CABG with left ITA (LITA) grafting of the LAD (LITA-LAD grafting), long-term 
survival was similar for those receiving either a right ITA (RITA) or RA graft to 
the circumflex system. However, RA grafting was associated with a lower 
prevalence of DSWI and respiratory complications. However, RA grafting was 
associated with lower prevalence of DSWI and respiratory complications. 
Contrary to our findings, a subgroup analysis in a study by Raja and colleagues 
[6] showed a trend toward increased risk for late mortality (hazard ratio [HR] 3.3; 
95% confidence interval [CI] 1.1-9.7) and a need for repeat revascularization 
(HR 3.1; 95% CI 1.2-8.2) with RA (n=124) grafting vs. RITA (n=103) grafting in 
diabetic patients undergoing CABG with LITA-LAD.  
 Ten-year results of the Radial Artery Patency and Clinical Outcomes Trial 
(RAPCO) [7] showed that in younger patients (<70 years of age, or <60 if 
diabetic) undergoing CABG with a LITA-LAD graft, the use of the RA as a 
second conduit confers superior survival despite equivalent patency to the RITA. 
Contrary to this finding, a recent meta-analysis of 8 propensity score–matching 
studies [4] comparing long-term survival of patients (not specifically diabetic 
patients) receiving a RITA vs. RA as a second conduit for CABG showed that 
RITA use was associated with superior long-term survival and freedom from 
repeat revascularization, with similar operative mortality and prevalence of 
DSWI when the skeletonized harvesting technique was used. Why, then, is the 
long-term difference in survival among patients receiving RA or RITA grafts 
observed in clinical trials and meta-analyses but not in studies specifically 
involving diabetic patients? The answer likely lies in differences between the life 
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expectancies of diabetic and non-diabetic patients. Because diabetic patients 
have shorter life expectancies than non-diabetic patients, the long-term survival 
benefit of one type of second arterial graft over another may not be observed in 
diabetic patients. However, this hypothesis requires further testing.   
 
6.5 Addition to Literature in Light of Systematic Review 
A systematic literature search was done to identify studies that already existed 
on this topic at the time of paper preparation/publication, so the addition to the 
literature that the study made could be effectively evaluated in light of existing 
knowledge on the subject. Details of this systematic review are given in the 
Appendix (see section 10.5). Briefly, we searched the literature for studies 
reporting the clinical outcomes of SITA plus RA grafting vs. BITA grafting in 
diabetic vs. non-diabetic patients. Studies not reporting clinical outcomes were 
excluded. Only two studies were identified that met the specified criteria. These 
included the studies by Hoffman et al [5] and Raja et al [6] described in the 
previous sections. However, these studies showed conflicting results. The study 
by Hoffman et al supported our finding that both arterial grafting strategies yield 
similar long-term survival in diabetic patients, but the study by Raja et al, 
contrary to our findings, showed that BITA grafting was associated with better 
long-term survival in diabetic patients. The study by Hoffman et al was based on 
908 diabetic patients, which yielded 202 match pairs for adjusted comparison, 
whereas the study by Raja et al was based on 227 diabetic patients. I believe 
that our study, by virtue of its larger sample size (1325 diabetic patients) and 
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robust propensity-matched analysis yielding 282 well-matched patient pairs, 
provides strong supporting evidence for our assertions and thus represents a 
valuable addition to the literature on this topic.  
 
6.6 Critical Commentary 
Help was taken from Critical Appraisal Skills Program (CASP) checklist for 




As mentioned in the introduction section of the manuscript, and in the 
background of the discussion section, this study addressed a clearly focused 
issue of identifying an arterial grafting strategy, SITA plus RA grafting or BITA 
grafting, that results in better short- and long-term outcomes in these patients. 
The introduction section of the manuscript, and the background of the 
discussion section of the paper, clearly explain the rationale and importance of 
the research question being addressed.  
 
6.6.2 Study Design  
This was a retrospective cohort study. An RCT comparing long-term outcomes 
of patients undergoing CABG with either BITA grafts or single ITA plus radial 
artery grafts would have been ideal. However, any meaningful trial comparing 
these strategies would have needed long-term follow-up (at least 10 years) 
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which is challenging and expensive. Therefore, studying this research question 
in a retrospective fashion was reasonable, and perhaps the only feasible way to 
study >10-year outcomes of CABG with BITA vs. single ITA plus radial artery 
grafting in diabetic patients.  
 
6.6.3 Participant Selection  
As for the other studies, Cleveland Clinic’s Cardiovascular Registry (CVIR) was 
used to identify the desired study population. Pharmacologically treated and 
diet-controlled diabetic patients were included. Patients with unknown diabetic 
status were excluded. We were unable to discriminate between type I and type 
II diabetes. This maybe important because the long-term survival after CABG of 
type 1 diabetic patients is worse than the survival of type II diabetic patients [8]. 
However, this was not mentioned in the limitations section of the paper. Patients 
were reliably classified into groups, BITA and SITA+RA, as these details are 
clearly mentioned in operative reports. 
 It was not mentioned in the paper whether this study required any 
additional data-collection apart from the data retrieved from CVIR. No additional 
data was collected for this study. However, chart review was done for 
verification purposes of unusual combinations of grafts.  
 It was also not mentioned in the paper why the patients were included 
from 1994 onwards instead of 1972, like the previous studies. The reason was 
that CABG cases in which radial artery grafts were used in diabetic patients 
were only available from 1994 onwards. There were not many radial artery 
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cases before that year. Though CABG cases with BITA grafts used in diabetic 
patients were available for comparison from much earlier years, we didn’t 
include them for fair comparison and only compared patients who underwent 
CABG with SITA+RA grafts from 1994 to 2011 with patients who underwent 
CABG with BITA grafts from 1994 to 2011. Furthermore, to adjust for medical 
and surgical advancements from 1994 to 2011, we adjusted for the date of 
surgery in the model to strengthen the results and conclusions that could be 
drawn from the analysis. 
 
6.6.4 Sample Size 
The unadjusted survival difference between the two study groups at 14 years 
was 15% (14-year survival after CABG: 51% for SITA+RA group and 66% for 
BITA group). To detect a difference of this magnitude, with a type I error rate 
(significance level) of 5%, and 360 patients in BITA group and 965 in SITA plus 
RA group, our unadjusted comparison was powered enough (>99% power). To 
detect the same 15% difference in survival, our propensity-matched comparison 
was powered enough (>90% power) with a type I error rate of 5%, and 268 
patients in each group. However, to detect a difference in survival of 10%, our 
propensity-matched comparison was only 65% powered. Please note that some 
criticize the idea of retrospective power calculation. However, it was done only 







The end-points of the study included hospital outcomes and long-term mortality. 
Please see 3.6.5 for a critical appraisal of our long-term mortality follow-up.  
 
6.5.6 Data Analysis  
As mentioned in the paper, the patient characteristics significantly differed 
between the two groups. To adjust for imbalances in measured characteristics 
and for fair comparison of outcomes, we performed matching based on 
propensity scores. A number of variables (detailed in the appendix of the paper) 
were considered in this analysis ranging from demographic variables, to cardiac 
and non-cardiac comorbidities, and date of operation. However, any patient 
factors not included in the propensity model that importantly affect outcomes 
may have biased our findings.  
 For the benefits of matching compared to other propensity score 
techniques please see “Propensity Matching” under 3.6.6.  
 Survival was assessed nonparametrically using the Kaplan-Meier 
method, and parametrically using a multiphase hazard model. Please see 
section 2.6.6 for details regarding this model and for explanation regarding use 






6.4.7 Results & Discussion 
The study showed that BITA versus SITA+RA grafting was associated with 
similar survival in diabetic patients undergoing CABG.  
 Survival was reported for up to 14 years after CABG. However, absolute 
risk reduction and hazard ratio were not reported in the manuscript. The results 
are believable because the study compared outcomes in a large number of 
diabetic and non-diabetic patients using data from a well-regarded registry and 
took appropriate measures to control for confounding.  
 The discussion clearly mentioned the principal findings of the study, and 
in the section of “findings in context”, we discussed the existing knowledge on 
the topic and compared our findings with the results of other studies. The 
limitations were also clearly mentioned.  
 The conclusions of the paper were supported by the data presented and 
mentioned the clinical implications of the study instead of just summarizing the 
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Similar Outcomes in Diabetes Patients After
Coronary Artery Bypass Grafting With
Single Internal Thoracic Artery Plus Radial
Artery Grafting and Bilateral Internal
Thoracic Artery Grafting
Sajjad Raza, MD, Eugene H. Blackstone, MD, Penny L. Houghtaling, MS,
Marijan Koprivanac, MD, Kirthi Ravichandren, MD, Hoda Javadikasgari, MD,
Faisal G. Bakaeen, MD, Lars G. Svensson, MD, PhD, and Joseph F. Sabik, III, MD
Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, and Department of Quantitative Health Sciences,
Research Institute, Cleveland Clinic, Cleveland, Ohio
Background. The purpose of this study was to deter-
mine in patients with diabetes mellitus whether single
internal thoracic artery (SITA) plus radial artery (RA)
grafting yields outcomes similar to those of bilateral
internal thoracic artery (BITA) grafting.
Methods. From January 1994 to January 2011, 1,325
diabetic patients underwent primary isolated coronary
artery bypass graft surgery with either (1) SITA plus RA
with or without saphenous vein (SV) grafts (n [ 965) or
(2) BITA with or without SV grafts (n [ 360); an internal
thoracic artery was used in all patients to graft the left
anterior descending coronary artery. Endpoints were
in-hospital outcomes and time-related mortality. Median
follow-up was 7.4 years, with a total follow-up of 9,162
patient-years. Propensity score matching was performed
to identify 282 well-matched pairs for adjusted
comparisons.
Results. Unadjusted in-hospital mortality was 0.52%
for SITA plus RA with or without SV grafts and 0.28% for
BITA with or without SV grafts, and prevalence of deep
sternal wound infection was 3.2% and 1.7%, respectively.
Unadjusted survival at 1, 5, 10, and 14 years was 97%,
88%, 68%, and 51% for SITA plus RA with or without SV
grafts, and 97%, 95%, 80%, and 66% for BITA with or
without SV grafts, respectively. Among propensity-
matched patients, in-hospital mortality (0.35% versus
0.35%) and prevalence of deep sternal wound infection
(1.4% versus 1.4%) were similar (p > 0.9) in the two
groups, as was 1-, 5-, 10-, and 14-year survival: 97%, 90%,
70%, and 58% for SITA plus RA with or without SV
grafting versus 97%, 93%, 79%, and 64% for BITA with
or without SV grafting, respectively (early p [ 0.8, late
p [ 0.2).
Conclusions. For diabetic patients, SITA plus RA with
or without SV grafting and BITA with or without SV
grafting yield similar in-hospital outcomes and long-term
survival after coronary artery bypass graft surgery.
Therefore, both SITA plus RA and BITA plus SV grafting
should be considered for these patients.
(Ann Thorac Surg 2017;104:1923–32)
! 2017 by The Society of Thoracic Surgeons
Forty percent of patients undergoing coronary arterybypass grafting (CABG) today have diabetes mellitus
[1]. Use of arterial grafts, compared with venous grafts, is
associated with better outcomes after CABG for diabetic
patients [2]. However, it remains unclear which arterial
grafting strategy—single internal thoracic artery (SITA)
plus radial artery (RA) grafting or bilateral internal
thoracic artery (BITA) grafting—results in better short-
and long-term outcomes for these patients. Therefore, we
sought to determine for diabetic patients whether SITA
plus RA grafting yields in-hospital outcomes and long-
term survival similar to those of BITA grafting.
Patients and Methods
From January 1994 to January 2011, 1,325 diabetic patients
with multisystem coronary artery disease underwent
Accepted for publication May 11, 2017.
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primary isolated CABG with either (1) SITA plus RA with
or without saphenous vein grafts (hereafter referred to as
SITA plus RA; n ¼ 965) or (2) BITA with or without
saphenous vein grafts (hereafter referred to as BITA;
n ¼ 360). An internal thoracic artery (ITA) was used in all
patients to graft the left anterior descending coronary
artery (LAD). Mean age was 59 " 8.8 years, and 83% were
men (Table 1).
Patients were identified and preoperative, operative,
and postoperative variables (Appendix E1) retrieved from
the prospective Cleveland Clinic Cardiovascular Infor-
mation Registry. This database is populated concurrently
with patient care and has been approved for use in
research by the Institutional Review Board, with patient
consent waived.
Variables and Definitions
A coronary artery system was considered importantly
stenotic if it contained 50% or greater diameter
obstruction. The majority (88%) of coronary arteries with
50% or greater stenosis that were grafted by either a
radial artery or a second ITA were severely stenosed
(70% or more); only 12% were moderately stenosed.
Incomplete revascularization was defined as failure to
graft any coronary system containing 50% or more ste-
nosis, or both LAD and circumflex coronary artery sys-
tems for 50% or greater left main trunk stenosis. Left
ventricular function was echocardiographically graded
as normal (ejection fraction [EF] 60% or more), mild (EF
40% to 59%), moderate (EF 25% to 39%), or severe (EF
less than 25%).
Endpoints
Endpoints were (1) in-hospital adverse outcomes defined
as for The Society of Thoracic Surgeons National database
(http://www.ctsnet.org/file/rptdataspecifications252_1_
forvendorspgs.pdf); and (2) time-related mortality. Vital
status after hospital discharge was obtained by routine
anniversary follow-up questionnaires supplemented
with data from the Social Security Death Master File
[3, 4], accessed on October 27, 2011, with a closing date
of April 27, 2011. A total of 9,162 patient-years of follow-
up data were available for analyses. Median follow-up
was 7.4 years, with 10% of survivors followed for at
least 13 years.
Statistical Analysis
All analyses were performed using SAS version 9.4
statistical software (SAS Institute, Cary, NC).
LONG-TERM SURVIVAL. Survival was assessed nonpara-
metrically using the Kaplan-Meier method [5] and para-
metrically using a multiphase hazard model [6]. The latter
involved resolving the number of hazard phases for
instantaneous risk of death (hazard function) and esti-
mating shaping parameters (for details, see: www.lerner.
ccf.org/qhs/software/hazard).
PROPENSITY SCORE MATCHING. Because patient characteris-
tics differed between the two groups (SITA plus RA and
BITA; Table 1), in the spirit of a “natural experiment” we
attempted to fairly compare outcomes using propensity
score–based matching [7–9]. That was accomplished in
two steps. First, a parsimonious multivariable logistic
regression was used to identify differences in preoper-
ative characteristics of patients in the SITA plus RA
group and BITA group to obtain insight into these dif-
ferences (see Appendix E1 for list of variables analyzed).
Bootstrap bagging for variable selection, with automated
analysis of 500 resampled data sets, was used to
accomplish this, followed by tabulating the frequency of
both single factors and closely related clusters of factors
[10]. We retained factors that occurred in 50% or more of
the bootstrap models (Supplemental Table E1). The C-
statistic for this parsimonious model was 0.83. Second,
the parsimonious model was augmented into a saturated
propensity model by including patient characteristics
that were not statistically significantly different between
groups, but represented demographic, cardiac, and
noncardiac comorbidities not represented (see Appendix
E1). The C-statistic for this model was 0.84. A propensity
score representing the probability of BITA group mem-
bership given the variables included in the propensity
model, regardless of whether the patient received BITA
grafts, was then calculated for each patient. A greedy
matching strategy [11] based on propensity scores alone
was used to match patients receiving SITA plus RA and
BITA, yielding 282 well-matched pairs (78% of possible
matches; Supplemental Fig E1). BITA cases with pro-
pensity scores deviating more than 0.10 from those of
SITA plus RA cases were considered unmatched. Stan-
dardized differences demonstrated that covariable bal-
ance was achieved across nearly all variables
(Supplemental Fig E2), and the two groups were
balanced with respect to the target vessel for RA and
second internal thoracic artery graft (Table 2).
MISSING VALUES. A number of variables examined in
multivariable analyses had missing values (see “Patients
with data available” in Table 1). Of the 35 variables used
for the propensity score, 18 had no missing data, 8 had
more than 0% but less than 2% missing data, 6 had
between 10% and 15%, and 3 had greater than 20%
missing data. The pattern of missing data appeared
arbitrarily, so “missing at random” was assumed. We
used fivefold multiple imputation [12] with a Markov
chain Monte Carlo technique to impute missing values
(SAS PROCMI; SAS Institute, Cary, NC). In multivariable
Abbreviations and Acronyms
BITA = bilateral internal thoracic artery
CABG = coronary artery bypass grafting
DSWI = deep sternal wound infection
EF = ejection fraction
ITA = internal thoracic artery
LITA = left internal thoracic artery
RA = radial artery
RITA = right internal thoracic artery
SITA = single internal thoracic artery
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modeling, for each imputed complete data set, we esti-
mated the regression coefficients and their variance–
covariance matrix. Then, following Rubin [12], we
combined estimates from the five models (SAS PROC
MIANALYZE; SAS Institute) to yield final regression
coefficient estimates, the variance–covariance matrix, and
p values.
PRESENTATION. Continuous variables are summarized as
mean ! SD, or 15th, 50th (median), and 85th percentiles
when values were skewed; comparisons were made using
Wilcoxon rank sum (nonparametric) tests. Categoric vari-
ables are summarized by frequencies and percentages;
comparisons were made using the c2 test or Fisher’s exact
test when the frequency was less than 5. Transformation of
scale of continuous variables was necessary to meet sta-
tisticalmodel assumptions; therefore, results of logistic and
multiphase hazard models are presented with their co-
efficients rather than odds or hazard ratios. Uncertainty is
expressed by confidence limits equivalent to !1 SE (68%).
Results
Patient Characteristics
Compared with patients receiving BITA grafts, patients
receiving SITA plus RA grafts were older and more likely
to be overweight and female (Table 1, Supplemental
Table E1). In addition, they were more likely to have
symptomatic heart failure, prior stroke, carotid disease,
hypertension, and medically treated diabetes.
Hospital Outcomes
Unadjusted in-hospital mortality was 0.52% for SITA plus
RA and 0.28% for BITA grafts, and prevalence of deep
sternal wound infection (DSWI) was 3.2% and 1.7%,
respectively (Table 3). In propensity-matched pairs, all
hospital outcomes and lengths of stay were similar in the
two groups (Table 3).
Long-Term Survival
Unadjusted survival at 1, 5, 10, and 14 years was 97%, 88%,
68%, and 51%, respectively, for the SITA plus RA group
and 97%, 95%, 80%, and 66% for the BITA group (Fig 1A).
Instantaneous risk of death was substantially elevated
early after surgery and then gradually decreased over the
first 6 months for both groups. Thereafter, risk of death
gradually increased over time for both (Fig 1B).
In propensity-matched patients, survival was similar in
the two groups: at 1, 5, 10, and 14 years, it was 97%, 90%,
70%, and 58% for the SITA plus RA group and 97%, 93%,
79%, and 64% for the BITA group, respectively (early
p¼ 0.8, late p¼ 0.2; Fig 2A). Instantaneous risk of deathwas
substantially elevated early after surgery for both groups
and gradually decreased during the first 6months for SITA
plus RA patients and the first 12 months for BITA patients.
Thereafter, risk of death gradually increased over time,
similarly for both groups (Fig 2B).
Long-term survival for unmatched SITA plus RA pa-
tients was lower than for unmatched BITA patients (p [log
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We have previously shown that BITA grafting with
complete revascularization maximizes long-term survival
of diabetic patients undergoing CABG and that off-pump
or on-pump surgery can be used with equal effectiveness
[2]. However, because BITA grafting was also associated
with increased risk of DSWI, we recommended that it be
used in diabetic patients whose risk of DSWI is low. The
RA is another commonly used arterial graft conduit that
has been shown to be associated with better clinical and
Table 2. Number of Bypasses by Conduit Type and Coronary Artery System
CABG Details
Before Matching After Matching
SITAþRA (n ¼ 965) BITA (n ¼ 360) SITAþRA (n ¼ 282) BITA (n ¼ 282)
No. (%) No. (%) No. (%) No. (%)
First ITA graft
To LADa 965 (100) 360 (100) 282 (100) 282 (100)
To LCx 3 (0.31) 3 (0.83) 1 (0.35) 2 (0.71)
To RCA 0 (0) 0 (0) 0 (0) 0 (0)
To diagonal 195 (20) 65 (18) 80 (28) 58 (21)
Radial artery graft
To LAD 11 (1.1) 0 (0) 2 (0.71) 0 (0)
To LCx 753 (78) 0 (0) 230 (82) 0 (0)
To RCA 184 (19) 0 (0) 52 (18) 0 (0)
To diagonal 141 (15) 0 (0) 32 (11) 0 (0)
Second ITA graft
To LAD 0 (0) 1 (0.28) 0 (0) 1 (0.35)
To LCx 0 (0) 270 (75) 0 (0) 207 (73)
To RCA 0 (0) 61 (17) 0 (0) 51 (18)
To diagonal 0 (0) 46 (13) 0 (0) 38 (13)
a Most internal thoracic artery (ITA) grafts to the left anterior descending coronary artery (LAD) were left rather than right: 959 (99%) in the single internal
thoracic artery plus radial artery (SITAþRA) group and 260 (72%) in the bilateral internal thoracic artery (BITA) group. Among propensity-matched
patients, 280 (99%) of the patients in the SITAþRA group and 214 (76%) in the BITA group had a left ITA to LAD graft.
CABG ¼ coronary artery bypass grafting; LCx ¼ left circumflex coronary artery; No. ¼ number; RCA ¼ right coronary artery.
Table 3. In-Hospital Outcomes
Outcome
Before Matching After Matching











Death 5 (0.52) 1 (0.28) 1 (0.35) 1 (0.35) >0.9
Deep sternal wound infection 31 (3.2) 6 (1.7) 4 (1.4) 4 (1.4) >0.9
Septicemia 21 (2.2) 2 (0.56) 5 (1.8) 2 (0.71) 0.2
Permanent stroke 11 (1.1) 3 (0.83) 3 (1.1) 3 (1.1) >0.9
Perioperative myocardial infarction 3 (0.31) 2 (0.56) 1 (0.35) 1 (0.35) >0.9
Reoperation for bleeding or tamponade 14 (1.5) 5 (1.4) 4 (1.4) 3 (1.1) 0.7
Atrial fibrillation 231 (24) 78 (22) 68 (24) 59 (21) 0.4
Renal failure 52 (5.4) 10 (2.8) 8 (2.8) 9 (3.2) 0.8
Renal failure requiring dialysis 5 (0.52) 0 (0) 2 (0.71) 0 (0) 0.16
Prolonged ventilation, >24 hours 16/228 (7.0) 8/169 (4.7) 7/94 (7.4) 6/132 (4.5) 0.4
Length of stay
>14 days 51 (5.3) 15 (4.2) 11 (3.9) 11 (3.9) >0.9
Hospital, days 9.8 # 6.0 8.6 # 5.7 9.0 # 4.4 9.0 # 6.0 0.3
Operative, days 7.4 # 4.9 7.2 # 5.1 7.0 # 3.1 7.1 # 5.3 0.9
Intensive care unit, hoursa 24/24/72 24/24/72 24/24/72 24/24/70 0.4
a Values are 15th/50th/85th percentiles.
BITA ¼ bilateral internal thoracic artery; No. ¼ number; RA ¼ radial artery; SITA ¼ single internal thoracic artery.
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angiographic outcomes than vein grafts [13, 14]. There-
fore, we sought to determine in diabetic patients whether
SITA plus RA grafting yields outcomes similar to those of
patients who undergo BITA grafting. We hypothesized
that SITA plus RA grafting would be associated with
lower occurrence of DSWI and similar long-term survival
compared with BITA grafting in diabetic patients under-
going CABG.
Principal Findings
We found that SITA plus RA grafting is not associated
with lower occurrence of DSWI compared with BITA
grafting in diabetic patients undergoing CABG. Both
surgical strategies carry similar surgical risk and yield
similar long-term survival after CABG in diabetic
patients.
Findings in Context
A number of studies are available comparing the out-
comes of SITA plus RA versus BITA grafting in patients
undergoing CABG [15], but data regarding use of SITA
plus RA versus BITA grafting specifically in diabetic
patients are scarce [16, 17]. Supporting our findings,
Hoffman and colleagues [16] showed that among 202
Fig 1. Unadjusted time-related death stratified by single internal thoracic artery plus radial artery (SITA þ RA [blue]) and bilateral internal
thoracic artery (BITA [red] grafting), n ¼ 1,325. Solid lines are parametric estimates enclosed within dashed 68% confidence bands equivalent to
#1 SE. (A) Survival. Each symbol represents a death, and vertical bars are confidence limits equivalent to #1 SE. (B) Instantaneous risk of death.
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well-matched diabetic patients undergoing CABG with
left ITA (LITA) grafting of the LAD (LITA-LAD grafting),
long-term survival was similar for those receiving either a
right ITA (RITA) or RA graft to the circumflex system.
However, RA grafting was associated with lower preva-
lence of DSWI and respiratory complications. Contrary to
our findings, a subgroup analysis in a study by Raja and
colleagues [17] showed a trend toward increased risk for
late mortality (hazard ratio 3.3, 95% confidence interval
1.1 to 9.7) and need for repeat revascularization (hazard
ratio 3.1, 95% confidence interval 1.2 to 8.2) with RA
(n ¼ 124) grafting versus RITA (n ¼ 103) grafting in dia-
betic patients undergoing CABG with LITA-LAD. We
believe that our study, by virtue of its larger sample size
and robust propensity-matched analysis, more accurately
reflects the truth.
Ten-year results of the Radial Artery Patency and
Clinical Outcomes Trial (RAPCO) [18] showed that in
Fig 2. Adjusted (propensity-matched) time-related death stratified by single internal thoracic artery plus radial artery (SITA þ RA [blue]) and
bilateral internal thoracic artery (BITA [red] grafting), n ¼ 564. Solid lines are parametric estimates enclosed within dashed 68% confidence bands
equivalent to #1 SE. (A) Survival. Each symbol represents a death, and vertical bars are confidence limits equivalent to #1 SE. (B) Instantaneous
risk of death.
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younger patients (less than 70 years of age, or less than 60
if diabetic) undergoing CABG with a LITA-LAD graft, use
of the RA as a second conduit confers superior survival
despite equivalent patency to the RITA. Contrary to this
finding, a recent meta-analysis of eight propensity score
matching studies [15] comparing long-term survival of
patients (not specifically diabetic patients) receiving a
RITA versus RA as a second conduit for CABG showed
that RITA use was associated with superior long-term
survival and freedom from repeat revascularization,
with similar operative mortality and prevalence of sternal
wound complications when the skeletonized harvesting
technique was used. Why, then, is the long-term differ-
ence in survival among patients receiving RA or RITA
grafts observed in clinical trials and meta-analyses but
not in studies specifically involving diabetic patients? The
answer likely lies in differences between the life expec-
tancies of diabetic and nondiabetic patients. Because
diabetic patients have shorter life expectancies than
nondiabetic patients, the long-term survival benefit of
one type of second arterial graft over another may not be
observed in diabetic patients. However, this hypothesis
requires further testing.
We believe that clinical decision making regarding the
arterial grafting strategy in diabetic patients should focus
on tailoring the operation to the individual patient.
Therefore, although we recommend that BITA grafting be
used in all diabetic patients whose risk of developing
DSWI is low, in diabetic patients at high risk of DSWI,
such as obese diabetic women with diffuse atherosclerotic
burden, use of SITA plus RA grafting should be
considered.
Study Limitations
This was a nonrandomized, observational, comparative
effectiveness study, and therefore patient selection may
play a role in our findings. To account for this, we used
propensity score matching to identify similar groups of
patients for fair comparison of outcomes. However, any
patient factors not included in the propensity model that
importantly affect outcomes might bias our findings. No
angiographic patency and repeat coronary intervention
data were included in the study. This was also a single-
center study, and hence findings may not be generalizable.
Conclusion
For diabetic patients, SITA plus RA grafting and BITA
grafting yield similar in-hospital outcomes and long-term
survival after CABG. Therefore, both SITA plus RA
grafting and BITA grafting should be considered in these
patients.
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DISCUSSION
DR WALTER MERRILL (Nashville, TN): Dr Raza and his col-
leagues from the Cleveland Clinic are to be congratulated for
bringing to our attention another contribution of the under-
standing of coronary artery disease and coronary artery bypass
operations. We owe much of our understanding of this condition
to the authors of this study and somany of their predecessors from
Cleveland. They have tackled the problem of reporting the results
of operations in more than 1,000 diabetic patients, and their study
includes appropriate statistical manipulation of their patient
population in order that we might get a better grasp on which
operation—single internal thoracic artery (SITA) plus radial artery
versus bilateral internal thoracic artery (BITA)—should be used in
these patients. The findings from their study have demonstrated
that it does not matter. The results, both short term and longer
term, are similar. I have three questions for Dr Raza.
Firstly, in all cases, the left anterior descending artery (LAD)
was grafted by an internal mammary artery. Does it matter if the
graft is from the left side or right side?
Secondly, an artery was considered diseased if it had greater
than a 50% diameter obstruction. This might be problematic,
especially if a radial artery was used to graft this vessel. Was this
done in some instances and what were the consequences?
And thirdly, we know that survival data from both groups were
comparable, but do you know anything about patency or rein-
terventions that might have been carried out on these patients?
Thank you.
DR RAZA: Thank you, Dr Merrill, for your encouraging com-
ments. Regarding your first question about left versus a right ITA
graft to the LAD, we did not specifically look into this, but we
know from other studies that the patency of left and right ITAs is
similar. However, in our study, most of the patients, 99% in the
single ITA plus radial artery graft group and 72% in the BITA
group, had a left ITA to the LAD.
Regarding your second question, we did consider 50% stenosis
significant enough for grafting, but the majority, about 88% of the
coronary arteries that were grafted by either a radial artery or
second ITA, had severe (! 70%) stenosis. Therefore, the majority
of the coronary arteries that were grafted either by a radial artery
or a second ITA were in the severe and not the moderate stenosis
range.
Regarding your third question about whether we studied the
angiographic outcomes or reinterventions on these patients, the
answer is that we did not, but we are in the process of looking into
the angiographic outcomes of radial artery grafts, particularly in
diabetic patients, and of studying the risk factors for occlusion.
One of the important questions that we will be studying regards
the influence of preoperative stenosis, that is, competitive flow, on
the long-term patency of a radial artery graft.
DR JOSEPH ARCIDI (Flint, MI): I am curious as to whether the
implication from your study is that you have a threshold for
using bilateral ITA grafting or whether you are changing and
transitioning to single plus radial, and if there is a threshold, is it
hemoglobin A1c levels? And a related question might be with
this small incidence of deep sternal wound infection, how do you
take the ITAs? Do you use adjunctive sternal closure methods
and the like? Thank you very much. Another great Cleveland
Clinic study.
DR RAZA: Thank you. That is a very important question. We
published a study in JTCVS in 2014 in which we showed that
bilateral ITA grafting is better than single ITA grafting for dia-
betic patients. However, there were certain patient populations
in which the risk of deep sternal wound infection was simply too
high, particularly in obese diabetic females who had diffuse
atherosclerotic burden and were at the greatest risk of having
these infections.
So the take-home message from the findings of this study is
that single ITA plus radial artery grafting could be equally
effective and should be considered, particularly in patient pop-
ulations whose risk of sternal wound infection is high.
As far as techniques that we have adopted for reducing the risk
of deep sternal wound infection at Cleveland Clinic are con-
cerned, we use the skeletonized approach for ITA harvesting.
That is one of the most important surgical techniques for
reducing the risk of sternal wound infection. We use prophylactic
antibiotics and clippers instead of razors. If time allows and the
blood sugar level of the patient is high, we ask that they work to
get it under control before surgery, if that is possible.
Those are some of the techniques that can reduce the risk of
deep sternal wound infection, allowing more patients to benefit
from bilateral ITA grafts. This study showed that single ITA plus
radial grafting could be equally effective in diabetic patients. So
patients who are not candidates for BITA grafting can benefit
from single ITA plus radial use. We can tailor the procedure to
individual patients based on their characteristics.
DR VINAY BADHWAR (Morgantown, WV): So just to follow up
on your comments, a little cautionary note on absolute contra-
indication based on size and being female, because obviously, as
you know well, there is some evidence in Europe that that is not
really a factor. So just a clarifying question on that, because I
missed it I think in your presentation and in your abstract. How
did you account for body mass index and being female for that
specific subset of these high-risk people? Were they covariates in
your model?
DR RAZA: We performed propensity matching, including a
variety of variables ranging from demographics to cardiac and
noncardiac comorbidities. Body mass index, age, and other
important factors that influence outcomes were included in the
model that we used to calculate propensity scores. Thus, the
propensity-matched patients were fairly well balanced in terms
of their body mass index, sex, age, and so on.
DR FAISAL BAKAEEN (Cleveland, OH): So if I might build up
on that, our preference at the Cleveland Clinic is to use a bilateral
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mammary. Now, you could substitute a bilateral mammary in
certain scenarios, certainly if you have a diabetic patient,
certainly a fragile diabetic patient, because controlled diabetes in
a nonobese patient, younger patient, will probably do better with
skeletonized bilateral mammaries, but if you have an older pa-
tient with fragile diabetes, A1c greater than 9, that might be the
kind of patient where you would substitute BITA with a radial
graft.
As mentioned from the floor before this, there is absolutely no
absolute indication for using bilateral mammary, and that would
stay our baseline preference. Radial artery may be a substitute in
select patients such as the ones that I mentioned.
DR BADWHAR: So to that point, did you have skeletonization
versus pedicle as a variable in your propensity match?
DR RAZA:We do not have those data, but in the most recent era
we have been using only a skeletonized approach, and our
sternal wound infection number in 2015 was 0 for patients un-
dergoing primary isolated CABG.
DR BADHWAR: It will be important I think in future work from
your group to help define that, because you may find that as a
new variable in The Society of Thoracic Surgeons database
moving forward next year.
DR BAKAEEN: Yes, and I do not know if that is mentioned in the
manuscript or not, but almost universally BITAs are skeleton-
ized. So it is a practice mode.
DR TSUYOSHI KANEKO (Boston, MA): If there was bias toward
doing a BITA on a diabetic patient, so, say, for instance, if the
surgeon thought that the patient was too obese and if the patient
was female and if you had done a BITA and if you do a propensity
match to that population, you may not be looking at the really high
risk population. Would that be a limitation in this study?
DR BAKAEEN: That is our current philosophy. Now, whether
that was reflected over the years of the study, we do not know,
but that is a retrospective study. We can never 100% eliminate
biases such as that or confounders.
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Supplemental (Online-Only) Material 
 
APPENDIX: VARIABLES CONSIDERED IN ANALYSES   
 
Demographics 
Age (y),a sex,a race (white, black,a othera), weight (kg), height (cm), weight/height ratio, 
body surface area (m2), body mass index (kg•m-2)a 
 
Acuity  
New York Heart Association functional class (I-IV),a emergency operation 
 
Cardiac comorbidity 
Prior myocardial infarction,a atrial fibrillation or flutter,a complete heart block or pacer,a 
heart failure,a ventricular arrhythmia, left ventricular dysfunction (none, mild, mild to 
moderate, moderate, moderate to severe, severe)a 
 
Noncardiac comorbidity 
Diabetes type (pharmacologically treated, insulin-dependent,a diet-controlleda), 
peripheral arterial disease,a carotid disease,a hypertension,a chronic obstructive 
pulmonary disease,a  history of smoking,a prior stroke,a bilirubin (mg•dL-1),a creatinine 
(mg•dL-1),a blood urea  
nitrogen (mg•dL-1),a hematocrit (%),a cholesterol (mg•dL-1: total,a high-density 
lipoprotein,a low-density lipoprotein), triglycerides (mg•dL-1)a 
 
Coronary anatomy 
Number of systems diseased (≥50% stenosis),a left main trunk (LMT) disease, LMT 
disease (≥70% stenosis), LMT disease (≥50% stenosis),a left anterior descending (LAD) 
system disease,a LAD system disease (≥70% stenosis), LAD system disease (≥50% 
stenosis), left circumflex (LCx) system disease,a LCx system disease (≥70% stenosis), 
LCx system disease (≥50% stenosis),a right coronary artery (RCA) system disease,a 
RCA system disease (≥70% stenosis), RCA system disease (≥50% stenosis)a 
 
Experience 
Date of operation (years since 1/1/1994)a  
______________________ 
 
a. Variable used in saturated model to calculate propensity scores. 
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Table E1:  Factors associated with BITA grafting (vs. SITA+RA grafting) 
among diabetic patients undergoing CABG (parsimonious model). 
 
Factor Estimate ± SE P-value Reliability (%)a 
Demographics    
     Younger ageb -0.30 ± 0.13      .02 73 
     Lower BMIc -0.91 ± 0.15    <.0001 66 
Symptoms    
   NYHA functional class    
 II -0.42 ± 0.19      .03 65 
 III / IV -0.82 ± 0.23      .0004 65 
Noncardiac comorbidities    
     Diet-controlled diabetes 0.68 ± 0.20      .0008 88 
     Higher hematocritd 1.1 ± 0.33      .001 52 
Experience    
     More recent date of 
 operation 0.82 ± 0.065    <.0001 91 
     Earlier date of operatione 5.0 ± 0.43    <.0001 91 
Intercept 3.6 ± 0.74    <.0001 — 
 
Note: C-statistic=.83              
 
 
a. Percent of times factor appeared in 500 bootstrap models. 
b. Exp(age/50), exponential transformation. 
c. (BMI/25)2, squared transformation. 
d. (Hematocrit/40)2, squared transformation. 
e. Log(date of operation, years from 1/1/1974), logarithmic transformation. 
 
BITA=bilateral internal thoracic artery; SITA=single internal thoracic artery; 









Figure E1. Mirrored histogram of distribution of propensity scores for SITA+RA 
vs. BITA (shaded area represents matched patient cohorts). Key: BITA=bilateral 


















Figure E2. Covariate balance plot of standardized differences before and after 
the propensity score matching on selected covariables. Key: BITA=bilateral 
internal thoracic artery; BMI=body mass index; COPD=chronic obstructive 
pulmonary disease; DM=diabetes mellitus; HF=heart failure; HTN=hypertension; 
IDDM=insulin-dependent diabetes mellitus; LMT=left main trunk disease; LV 
dysfunc.=left ventricular dysfunction; NYHA=New York Heart Association; 
PAD=peripheral arterial disease; RA=radial artery; SITA=single internal thoracic 














Figure E3. Time-related death stratified by SITA+RA vs. BITA matched (solid 
lines) and unmatched (dashed lines) groups. Curves are Kaplan-Meier 
estimates with associated 68% confidence limits (vertical bars). Key: 
BITA=bilateral internal thoracic artery; SITA+RA=single internal thoracic artery 








Academic Importance of Papers 
 
The study that forms the basis of chapter 2 (Research Question 1) got accepted 
for presentation at the Forty-ninth Annual Meeting of The Society of Thoracic 
Surgeons (STS), Los Angeles, CA, Jan 26–30, 2013, and I was selected as the 
STS poster crawl finalist for presenting this study. This study was published in 
Annals of Thoracic Surgery, which is one of the flagship cardiac surgery 
journals, and the official journal of the Society of Thoracic Surgeons and the 
Southern Thoracic Surgical Association. This paper was accompanied by an 
editorial written by Drs. Arie Pieter Kappetein and Ruben L.J. Osnabrugge from 
the department of thoracic surgery, Erasmus Medical Center, Netherlands [1]. A 
story describing this study was also featured in ‘Science Daily.  
 The study that forms the basis of chapter 3 (Research Question 2) was 
published in the Journal of Thoracic & Cardiovascular Surgery, which is one of 
the flagship cardiac surgery journals, and official journal of the American 
Association of Thoracic Surgery. Two editorials accompanied this study; one 
written by Drs. Mani Arsalan & Michael Mack from Baylor Research Institute, 
Baylor Scott & White Health, Dallas, TX [2], and the other by Dr. Paul Kurlansky 
from Columbia University NewYork, NY [3]. This study has been cited 24 times 
to date and has received coverage in Medscape Medical News, Clinical 
Endocrinology News, Hospitalist News, Cardiology News, ACS Surgery News 
and Thoracic Surgery News. The American Association of Thoracic Surgery 
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organized a press release accompanying this article’s publication in Journal of 
Thoracic & Cardiovascular Surgery.  
 The study that forms the basis of Chapter 4 (Research Question 3) got 
accepted for oral presentation in the Scientific Sessions of the American College 
of Cardiology (ACC), held in April 2016 in Chicago, IL. It was published in 
Journal of American College of Cardiology in August 2017, which is the number 
one ranked cardiovascular journal in US with impact factor of 17.759 (2015). 
Drs. David P. Taggart and Umberto Benedetto from University of Oxford, UK 
and University of Bristol, UK, respectively, wrote an editorial on this study [4].  
 The study that is the basis of chapter 5 (Research Question 4) was 
accepted for presentation as the lead-off paper in the Plenary Session of the 
94th Annual Meeting American Association of Thoracic Surgery (AATS), April 26 
to 30, 2014, Toronto, Canada. The Plenary Session features presentations on 
some of the most cutting-edge research being performed in cardiothoracic 
surgery – all with the goal of improving outcomes and developing best practices. 
This study received front page coverage in Thoracic Surgery News and AATS 
Daily News. It was published in the Journal of Thoracic & Cardiovascular 
Surgery, which is one of the flagship cardiac surgery journals, and the official 
journal of the American Association of Thoracic Surgery and the Western 
Thoracic Surgical Association. Dr. Andrea Carpenter of the University of Texas 
Health Science Center, San Antonio, TX [5], wrote editorial commentary on this 
paper. Drs. Michael E. Halkos and Robert A. Guyton also commented on this 
study in their editorial [6]. This article has been cited 68 times to date and was 
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also cited in the 2014 European Society of Cardiology/European Association for 
Cardiothoracic Surgery Guidelines on myocardial revascularization. 
 The study that forms the basis of Chapter 6 (Research Question 5) was 
accepted for presentation at the Southern Thoracic Surgical Association Annual 
Meeting, held in Naples, Florida, from November 11 to 14, 2016, and was 
accepted for publication in Annals of Thoracic Surgery, which is one of the 
flagship cardiac surgery journals, and the official journal of the Society of 
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8.1 Importance of Multidisciplinary Research Team 
The most important thing that I learned from my research work included in the 
thesis is the importance of a multidisciplinary research team in conducting high-
quality streamlined research. As described in Chapter 6 of the book 
“Kirklin/Barratt-Boyes Cardiac Surgery”, key players in such a team include a 
clinical-investigator, database manager, data gatherers, individuals assessing 
the quality of data, statistical programmers, expert statisticians and other 
professionals helping with different aspects of the research process. With the 
growing sophistication of data management and analytic tools, it becomes 
necessary to assemble a research group with varied roles and expertise, all 
focused on the goals of clinical investigation.  
 As described in the book mentioned above, the roles of key-personnel 
are as follows:  
 A clinical-investigator in collaboration with key individuals in data 
management, statistics, and study coordination, develop the clinical question, 
define the study group of interest, identify variables and end points of interest, 
review the literature, and develop all elements of a study protocol, adjudicate 
data quality, often gather values for variables in addition to the core data 
elements, help interpret the analyses performed, put them into clinical context, 
present the findings to colleagues, and write manuscripts.  
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 The database manager is at the interface between data gathering and 
data analysis. The assembly of data for meaningful analysis is often complex, 
requiring information to be retrieved from a variety of electronic sources. 
Database managers help with this important task.  
 The statistical programmer converts data from database format into 
analysis data sets that make sense to the statistician.  
 Statisticians help the clinical investigator in choosing the most 
appropriate analytic methodology for a given study and perform the statistical 
analysis.  
 Other members of such research teams may include individuals who 
verify data, perform patient follow-up, do financial analysis, write grants, produce 
medical illustrations or computer graphics, and engage in many other support 
roles.  
 
8.2 Development of Analysis Plan 
In the department of Cardiac Surgery at the Cleveland Clinic, the inception of 
each study was followed by the process of writing the study proposal and 
submitting it to the research committee for approval. The committee used to 
review the proposal and either approve it with or without revisions, or disapprove 
it on the basis of feasibility and importance of research question. Every research 
proposal included a title, the names of investigators, the background of the 
project and key references, a clear research question, study group definition, 
end-points, required variables from databases, variables needing data-
collection, proposed data-analysis methodology, and timeline and deliverables.  
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 However, with time the need for a more comprehensive study roadmap 
was realized particularly for data analysis. Therefore, in an effort to improve and 
streamline the process of research, detailed analysis plans were developed for 
each study right after the proposal was approved. Statisticians in collaboration 
with the investigators developed these analysis plans. A typical analysis plan 
describes the different phases of a study, the work and analysis to be done 
during each phase, and the statistical methods to be used during each phase.  
 
 
8.3 Best Data-collection Practices  
 
Data Collection is an important part of any research study. Inaccurate data 
collection can lead to invalid results. The study that is the basis of Chapter 4 
required extensive data-collection because from about 2000 to 2004, the 
diagnostic catheterization data was not routinely collected in existing registries. 
Therefore, I collected the missing diagnostic catheterization data. In the 
beginning, I was planning to collect this data in an excel sheet. However, I 
realized that collecting data in an excel sheet has its pitfalls as they are 
susceptible to trivial human errors. Instead, collecting data directly into the 
database, with preexisting variables’ fields, was a better idea, as the registry 
data-collection interface was designed to minimize human errors in data-
collection. Collecting data directly into the database was only possible because I 
was collecting missing data on variables already existing in the database.  
 In one of my other studies (not part of this thesis), I had to collect data on 
new variables, not existing in the database. For that project, it was not possible 
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to collect data directly in the database, as there was no field for those variables. 
For that study, I initially planned to use excel sheets for data-collection 
purposes. However, the research team introduced me to an online tool known 
as REDCap (Research Electronic Data Capture), which is a secure web 
application for building and managing online databases. While REDCap can be 
used to collect virtually any type of data, it is specifically geared to support 
online or offline data capture for research studies and operations. For my future 
studies, instead of collecting data in an excel sheet, I would prefer using 
REDCAP or a pre-existing database application.  
 
8.4 Critical Role of Data Integration & Cleaning  
I also learned from my projects that extracting data from different registries for 
the same patients, and then programming these data into analyzable format are 
daunting tasks that require expert and experienced statistical programmers. 
Data cleaning for analysis purposes can take much longer than anticipated but 
is critical for accurate analysis, particularly if the data is being combined after 
extraction from multiple data sources. Several issues can arise during this 
process, which have to be resolved appropriately before processing. Once data 
integration is complete, it might be beneficial to manually check data on some 
patients for verification, as this would ensure that the data merging from different 





8.5 Importance of Exploratory Data Analysis 
While working on the project, which is basis of Chapter 6, I made a fundamental 
mistake of not carefully reviewing the results of the initial exploratory data 
analysis. The statistician went on to do the analyses and when I received the 
analysis report I found some odd combinations of grafting strategies, which I 
could have identified in the initial descriptive analysis results. For example, I 
found that for some patients, multiple bypass grafts were going to the same 
coronary artery or one graft was going to multiple coronary arteries in a fashion 
that was not surgically possible. I reviewed the charts of patients with odd 
combinations of grafts and found some errors in the way these grafts were 
coded. I corrected this error, but the whole analysis had to be done again which 
led to wastage of precious time and resources. This experience emphasizes the 
critical role of exploratory data analysis and review of the descriptive statistics 
before performing in-depth sophisticated analyses.  
 
8.6 Applicability of Past Data to Contemporary Patients 
I learned from the peer-review process of my manuscripts that the value of 
observations obtained over a long period is often questioned because patient 
risk factors change with time and advances occur in surgical and medical 
therapy. Therefore, to account for patient factors, operative techniques, and 
medical therapies that may have changed over time and affected survival, but 




8.7 Accounting for Selection Bias in Observational Studies  
One of the limitations of using observational data to compare the outcomes of 
any two treatments or interventions (like patients receiving CABG vs. PCI, or 
patients receiving single vs. bilateral ITA grafts) is the difference in the baseline 
characteristics of the groups. These differences result from non-random 
assignment of patients into the comparison groups leading to selection bias. If 
these differences are not accounted for, they can significantly confound, or 
render such comparisons invalid. Therefore, it is important to adjust for these 
differences in order to make valid comparisons. Several statistical techniques 
exist that can be utilized in an attempt to balance these baseline characteristics 
in the nonrandomized subjects. These include a multivariable adjustment and 
the use of propensity scores. It is important to note that the effectiveness of 
these techniques in reducing bias depends on the comprehensiveness of the 
risk factors available for analysis. This is particularly true for studies using 
administrative data, as these databases are not clinically enriched. The 
Cardiovascular Information Registry (CVIR) of the Cleveland Clinic is a clinical 
registry designed for research purposes and therefore has much greater clinical 
granularity. All studies included in this thesis are based on data from CVIR and 
therefore a wide variety of demographic, cardiac comorbidities, non-cardiac 
comorbidities and other patient characteristics were available to make the 
statistical risk adjustment process thoroughly rigorous. Therefore, these studies 
present high quality observational evidence for clinical decision-making. The 
academic success of these studies, mentioned in Chapter 7, further highlights 
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the importance given to them by peers and relevant clinical societies. It is 
important to note, however, that these studies nonetheless continue to be 
limited by a reliance on measured variables. The unmeasured clinical conditions 
represent a source of residual confounding for any observational study. Only 
randomized comparisons can be balanced in terms of both measured and 
unmeasured confounders. However, it is also important to note that randomized 
controlled trials are not always feasible for studying the comparative 
effectiveness of surgical therapies because of a lack of equipoise. Moreover, for 
studying long-term outcomes (15-20) years in case of most studies presented in 
the thesis) of different surgeries or surgical techniques, long-term follow-up data 
is needed which is not always possible to obtain due to lack of resources and 
loss-to-follow-up given the long time period.  
 In support of using observational data for clinical research, I would also 
like to mention here an excerpt from a paper by Donald B Rubin, who was the 
John L. Loeb Professor of Statistics at Harvard University, where he had been 
professor since 1983, and Department Chair for 13 of those years. He has 
published widely regarding causal inference in experiments and observational 
studies. In a paper he published in the Journal Statistics in Medicine in 2007 [1] 
he wrote “For estimating causal effects of treatments, randomized experiments 
are generally considered the gold standard. Nevertheless, they are often 
infeasible to conduct for a variety of reasons, such as ethical concerns, 
excessive expense, or timeliness. Consequently, much of our knowledge of 
causal effects must come from non-randomized observational studies”. In this 
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article, he advocates the position that observational studies can and should be 
designed to approximate randomized experiments as closely as possible. In his 
other widely cited papers he describes the role of propensity scores in 
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This thesis provides further knowledge about how to improve the outcomes of 
coronary revascularization. The findings of the research work included in this 
thesis have major implications for clinical practice and can help healthcare 
providers in improving the outcomes of their diabetic patients undergoing CABG. 
They strongly suggest maximizing the use of internal thoracic artery grafts in 
diabetic patients due to their superior patency and association with better long-
term survival. They suggest using radial artery grafts in diabetic patients in 
whom risk of deep sternal wound infections is high. Given that 50% of all 
patients undergoing CABG today are diabetics and this proportion is increasing, 
the findings of these studies have great relevance for this important and growing 
patient population. In addition to answering some very important questions, this 
work raises some more questions. These include: 
1) We found that the proportion of patients presenting for CABG who have 
diabetes increased each year over the last 4 decades, as did the 
proportion with cardiovascular risk factors. Thus, compared with diabetics 
undergoing operation in the 1970s, 1980s, and 1990s, those operated on 
more recently were more likely to be obese and present with more 
comorbidities and advanced coronary artery disease. Does the 
nationwide data also show similar trends?  
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2) We found that diabetes does not influence long-term patency of internal 
thoracic artery and saphenous vein grafts. Is this the case with other 
arterial grafts too, such as radial artery grafts and gastroepiploic artery 
grafts? 
3) We found that bilateral ITA grafting with complete revascularization is 
associated with better long-term survival and off-pump CABG or on-pump 
CABG yield similar results in diabetic patients undergoing CABG. Does a 
similar scenario exist in non-diabetic patients? 
4) We found that SITA plus RA grafting vs. BITA grafting is associated with 
similar long-term survival in diabetic patients undergoing CABG. Is this 
also the case in non-diabetic patients? Also, what is the incremental 
benefit of third arterial graft in diabetic and non-diabetic patients 
undergoing CABG?  
 The research work presented in the thesis has led me to become a better 
researcher. It has equipped me with the tools to work as an independent 
researcher who can design and execute studies to answer important questions 
through the use of real-world data. It also provides valuable guidance regarding 
the way in which real-world data can be used to provide insights into appropriate 










10.1 Systematic Review for Research Question 1 Presented in Chapter 2 
Purpose 
The purpose of this systematic literature search was to identify prediction 
models that predict long-term survival after CABG vs. PCI to compare the 
strength and limitation of our risk model against those. 
 
Methods 
Types of Studies Included 
We sought to include randomized controlled trials and observational studies in 
this systematic review.  
Inclusion Criteria: Models predicting long-term mortality/survival (at least 5 
years) after CABG vs. PCI.  
Exclusion Criteria: Models predicting only hospital mortality or early to midterm 
mortality (<5 years) were excluded.  
Review of Studies 
This was done by a single individual rather than two independent individuals 
which is the norm for systematic reviews because it was undertaken as part of a 








Electronic databases like Ovid Medline, PubMed, and Embase, and the 
websites of highly relevant journals like Annals of Thoracic Surgery and Journal 
of Thoracic & Cardiovascular Surgery were searched for studies. Reference lists 
of relevant articles were also screened.  
Search Strategy: 
The search strategy included both free text and controlled vocabulary for the 
concept of models predicting long-term survival after CABG vs. PCI.   
Search Limitations:  
-The search was performed in September 2017 and was restricted to January 
2013. This was done because the idea of the systematic search was to identify 
studies that already existed on this topic at the time of paper 
preparation/publication so that the addition to the literature that the study made 
could be effectively evaluated in the light of existing knowledge on the subject.  
-Studies were excluded if not in English language.  
 
Quality Assessment 
A careful and detailed assessment of study methodology documenting 
methodological strengths and weaknesses was performed using PROBCAST 





Data extraction and Analysis 
Data was extracted based on a pre-specified list of elements including the 




From the initial literature search, 124 articles were identified after removing the 
duplicates. Of these, 117 were excluded after title and abstract review. Of the 7 
studies [See references 1-7 below] selected for full-text review, 6 were excluded 
because they only predicted short term or mid-term survival (less than 5 years). 
Finally, only one study was identified that met the specified inclusion criteria 























Records identified through 
database searching 
(n = 145) 
Additional records identified 
through other sources 
(n = 5) 
Records after duplicates removed 
(n = 124) 
Records screened 
(n =   124) 
Records excluded 
(n =   117) 
Full-text articles assessed 
for eligibility 
(n =  7) 
Full-text articles excluded, 
with reasons 
(n =  6) 
6 excluded because no 
long-term survival 
prediction (at least 5 
years) 
Studies included in 
qualitative synthesis 
(n =  1) 
Quantitative synthesis 








1. Were appropriate data sources used, e.g. cohort, RCT or nested case-
control study data? 
Yes, registry data was used.  
 
2.Were all inclusions and exclusions of participants appropriate? 
Yes. However, it was not clear whether the model is only for patients undergoing 
first time revascularization or repeat revascularization.  
 
3.Were participants enrolled at a similar state of health, or were predictors 
considered to account for differences? 




1.Were predictors defined and assessed in a similar way for all 
participants in the study? 
Yes 
 
2.Were predictor assessments made without knowledge of outcome data? 
Yes 
 
3.Are all predictors available at the time the model is intended to be used? 
Yes  
 





1.Was a pre-specified outcome definition used? 
Yes 
 
2.Were predictors excluded from the outcome definition? 
Yes 
 










Sample Size and Participant Flow 
 
1.Were there a reasonable number of outcome events? 
Yes 
 




3.Were all enrolled participants included in the analysis? 
Yes 
 





1.Were non-binary predictors handled appropriately? 
Yes 
 
2.Was selection of predictors based on univariable analysis avoided? 
No mention that selection of predictors was based on univariate analysis.  
 
3.Was model overfitting (optimism in model performance) accounted for, 
e.g. using bootstrapping or shrinkage techniques? 
The C statistic was estimated with bootstrapping 
 
4.Were any complexities in the data (e.g. competing risks, multiple events 
per individual) accounted for appropriately? 
The end-point studied was death and not any longitudinal outcome so there 
were no multiple events per individual.  
 
5.Do predictors and their assigned weights in the final model correspond 
to the results from multivariable analysis? 
Yes 
 
6.For the model or any simplified score, were relevant performance 




7.Was the model recalibrated or was it likely (based on the evidence 
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10.2 Systematic Review for Research Question 2 Presented in Chapter 3 
 
Purpose 
The purpose of this systematic literature search was to identify studies reporting 
the cost of CABG in diabetic vs. non-diabetic patients. 
 
Methods 
Types of Studies to be Included 
We sought to include randomized controlled trials and observational studies in 
this systematic review.  
Inclusion Criteria: Studies reporting the cost of CABG in diabetic vs. non-
diabetic patients.  
Exclusion Criteria: Studies only reporting cost of CABG in either diabetic or non-
diabetic patients, and not both.  
Review of Studies 
This was done by a single individual rather than two independent individuals 
which is the norm for systematic reviews because it was undertaken as part of a 
doctoral dissertation.  
Searches 
Sources:  
Electronic databases like Ovid Medline, PubMed, and Embase, and the 
websites of highly relevant journals like Annals of Thoracic Surgery and Journal 
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of Thoracic & Cardiovascular Surgery were searched for studies. Reference lists 
of relevant articles were also screened.  
Search Strategy:  
The search strategy included both free text and controlled vocabulary for the 
concepts of cost of CABG in diabetic vs. non-diabetic patients.  
Search Limitations:  
-The search was performed in September 2017 and was restricted to November 
2014. This was done because the idea of the systematic search was to identify 
studies that already existed on this topic at the time of paper 
preparation/publication so that the study’s addition to the literature could be 
effectively evaluated in the light of existing knowledge on the subject.  
-Studies were excluded if not in the English language.  
Quality Assessment 
A careful and detailed assessment of study methodology documenting 
methodological strengths and weaknesses was performed using Newcastle 
Ottawa scale.  
Data Extraction and Analysis 
Data was extracted based on a pre-specified list of elements including number 
of patients in each comparison group. Quantitative analysis was not performed.  
 
Results  
From the initial literature search, 30 articles were identified after removing the 
duplicates. Of these, 26 were excluded after title and abstract review, and 1 
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study was excluded because we were unable to make from the abstract whether 
the study met the inclusion criteria or not and the full-text was not retrievable for 
further review. Three studies [See references 1-3 below] were selected for full-
text review and all three were finally included as they met the inclusion criteria 
(see PRISMA diagram below). Table 1 provides the characteristics of the 
included studies. Quality assessment based on the Newcastle-Ottawa scale for 

























Records identified through 
database searching 






















Additional records identified 
through other sources 
(n = 3) 
Records after duplicates removed 
(n = 30) 
Records screened 
(n =   30) 
Records excluded 
(n =   27) 
Full-text articles assessed 
for eligibility 
(n =  3) 
Full-text articles excluded, 
with reasons 
(n =  0) 
Studies included in 
qualitative synthesis 
(n =  3) 
Quantitative synthesis 





Table 1 Study Characteristics 
 
 





Stewart et al 1998 114 198 Hospital cost  
Abizaid et al 2001 96 509 1-year cost 




Table 2 Quality Assessment based on Newcastle-Ottawa scale  
 
Study Design Selection Comparability Outcomes Total 
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10.3 Systematic Review for Research Question 3 Presented in Chapter 4 
 
Purpose 
The purpose of this systematic literature search was to identify studies reporting 
the influence of diabetes on long-term coronary artery bypass graft patency.  
 
Methods 
Types of studies to be included 
We sought to include randomized controlled trials and observational studies in 
this systematic review.  
Inclusion Criteria: Studies reporting mid to long-term (at least 5 years) 
angiographic outcomes of ITA and SV grafts in diabetic vs. non-diabetic patients 
were included.  
Exclusion Criteria: Studies reporting only short-term patency (<5 years), or 
studies reporting the influence of diabetes on the overall patency of bypass 
grafts and not individually for ITA and SV grafts were excluded.  
Review of Studies 
This was done by a single individual rather than two independent individuals 
which is the norm for systematic reviews because it was undertaken as part of a 








Electronic databases like Ovid Medline, PubMed, and Embase, and the 
websites of highly relevant journals like Annals of Thoracic Surgery and Journal 
of Thoracic & Cardiovascular Surgery were searched for studies. Reference lists 
of relevant articles were also screened.  
Search Strategy:  
The search strategy included both free text and controlled vocabulary for the 
concepts of internal thoracic artery and saphenous vein graft patency in diabetic 
vs. non-diabetic patients. 
Search Limitations:  
-The search was performed in September 2017 and was restricted to May 2016. 
This was done because the idea of the systematic search was to identify studies 
that already existed on this topic at the time of paper preparation/publication so 
that the study’s addition to the literature could be effectively evaluated in the 
light of existing knowledge on the subject.  
-Studies were excluded if not in English language.  
Quality Assessment 
A careful and detailed assessment of study methodology documenting 
methodological strengths and weaknesses was performed using the Newcastle 





Data Extraction and Analysis 
Data was extracted based on a pre-specified list of elements including the 
number of patients in each comparison group. Quantitative analysis was not 
performed.  
Results  
From the initial literature search, 77 articles were identified after removing the 
duplicates. Of these, 68 were excluded after title and abstract review. Of the 9 
studies [See references 1-9 below] selected for full-text review, 2 were excluded 
because only early patency was reported for bypass grafts, 1 was excluded 
because the influence of diabetes on patency was not reported individually for 
ITA and SV grafts, 1 was excluded because I was unable to delineate whether 
the effect of diabetes was reported separately for ITA and SV grafts or just the 
combined effect was provided, and 1 was excluded because of non-availability 
of full-text (see PRISMA diagram below). Table 1 provides the characteristics of 
the 3 included studies. Quality assessment based on the Newcastle-Ottawa 

























Records identified through 
database searching 
(n = 103) 
Additional records identified 
through other sources 
(n = 6) 
Records after duplicates removed 
(n = 77) 
Records screened 
(n =   77) 
Records excluded 
(n =   68) 
Full-text articles assessed 
for eligibility 
(n =  9) 
Full-text articles excluded, 
with reasons 
(n =  6) 
 
- 3 excluded because only 
early patency was 
reported for bypass grafts 
- 1 excluded because 
influence of diabetes on 
patency was not reported 
individually for ITA and SV 
grafts 
- 1 excluded because of 
being unable to delineate 
whether the effect of 
diabetes given was 
reported separately for ITA 
and SV grafts or just 
combined effect provided. 
- 1 excluded because full-
text was not availavle 
 
Studies included in 
qualitative synthesis 
(n =  3) 
Quantitative synthesis 





Table 1 Study Characteristics 
 
 
Study Year No. of Grafts in 
Diabetic Patients  









Hwang et al 2010 ITA=332 ITA=554 81 months 
Deb et al 2014 SV grafts in 61 
diabetic patients 
SV grafts in 253 
non-diabetic 
patients 
≤ 5 years 
 
 
Table 2 Quality Assessment based on Newcastle-Ottawa scale  
 
Study Design Selection Comparability Outcomes Total 



























* * * * ** * * * 9 
Deb et al Cohort 
Study 
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10.4 Systematic Review for Research Question 4 Presented in Chapter 5 
 
Purpose 
To identify studies reporting the comparative effectiveness of (1) single internal 
thoracic artery (SITA) versus bilateral internal thoracic artery (BITA) grafting, (2) 
complete versus incomplete revascularization, and (3) off-pump versus on-pump 
CABG in terms of long-term survival in diabetic patients undergoing CABG. 
 
Methods 
Types of Studies to be Included 
We sought to include randomized controlled trials or observational studies in this 
systematic review.  
Inclusion Criteria 
Studies reporting the long-term survival (at least 10 years) with or without early 
outcomes of studied surgical techniques specifically in diabetic patients were 
included.  
Exclusion Criteria 
Studies reporting less than 10-year long-term survival were excluded.  
Review of Studies 
This was done by a single individual rather than two independent individuals 
which is the norm for systematic reviews because it was undertaken as part of a 






Electronic databases like Ovid Medline, PubMed, and Embase, and the 
websites of highly relevant journals like Annals of Thoracic Surgery and Journal 
of Thoracic & Cardiovascular Surgery were searched for studies. Reference lists 
of relevant articles were also screened.  
Search Strategy:  
The search strategy included both free text and controlled vocabulary for the 
concepts of surgical techniques compared in this study. These included: (1) 
SITA versus BITA grafting, (2) complete versus incomplete revascularization, 
and (3) off-pump versus on-pump CABG. Separate searches were conducted 
for each of these three comparative surgical strategies.  
Search Limitations:  
The search was performed in September 2017 and was restricted to April 2014. 
This was done because the idea of the systematic search was to identify studies 
that already existed on this topic at the time of paper preparation/publication so 
that the study’s addition to the literature could be effectively evaluated in the 
light of existing knowledge on the subject.  
-Studies were excluded if not in the English language.  
Quality Assessment 
A careful and detailed assessment of study methodology was done using the 




Data Extraction and Analysis 
Data was extracted based on a pre-specified list of elements including number 
of patients in each comparison group. Quantitative analysis was not performed.  
 
Results  
From the initial literature search for BITA vs. SITA grafting, 80 articles were 
identified after removing the duplicates. Of these, 67 were excluded after title 
and abstract review. Of the 13 studies [See references 1-13 below] selected for 
full-text review, 8 were excluded because long-term survival was not reported 
and 1 study was excluded because the results were not risk-adjusted (Figure 1). 
Table 1 provides the characteristics of the 4 included studies. Quality 
assessment based on the Newcastle-Ottawa scale for included studies retained 
for qualitative synthesis is provided in Table 2.  
 From the initial literature search for off-pump vs. on-pump CABG, 152 
articles were identified after removing the duplicates. Of these, 150 were 
excluded after title and abstract review. Of the 2 studies [See references 14 & 
15 below] selected for full-text review, 1 was excluded because long-term 
survival was not reported (Figure 2). Study characteristics and quality 
assessment based on the Newcastle-Ottawa scale for the included study are 
given in Tables 3 and 4, respectively.   
 From the initial literature search for complete vs. incomplete 
revascularization, 30 articles were identified after removing the duplicates. Of 
these, 29 were excluded after title and abstract review. One study [See 
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reference 16 below] was selected for full-text review but it was also excluded 





Table 1 Study Characteristics for BITA vs. SITA comparison 
 
Study Year Patients in SITA 
group 





Lytle et al 1999 601 211 12 years 
Endo et al 2003 277 190 14 years 
Steven et al 2004 419 214 16 years 




Table 2 Quality Assessment based on Newcastle-Ottawa scale for studies in BITA vs. SITA comparison 
 
Study Design Selection Comparability Outcomes Total 














































Table 3 Study Characteristics for Off-pump vs. On-pump comparison 
 












Table 4 Quality Assessment based on Newcastle-Ottawa scale for studies in Off-pump vs. On-pump 
comparison 
 
Study Design Selection Comparability Outcomes Total 
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Records identified through 
database searching 
(n = 151) 
Additional records identified 
through other sources 
(n = 1) 
Records after duplicates removed 
(n = 80) 
Records screened 
(n =  80) 
Records excluded 
(n =   67) 
Full-text articles assessed 
for eligibility 
(n =  13) 
Full-text articles excluded, 
with reasons 
(n =  9) 
 
8 studies excluded 
because long-term (at 
least 10 year) outcomes 
not reported.  
1 study excluded because 
results were not risk-
adjusted. 
Studies included in 
qualitative synthesis 
(n =  4) 
Quantitative synthesis 



























Records identified through 
database searching 
(n = 219) 
Additional records identified 
through other sources 
(n = 1) 
Records after duplicates removed 
(n = 152) 
Records screened 
(n =  152) 
Records excluded 
(n =   150) 
Full-text articles assessed 
for eligibility 
(n =  2) 
Full-text articles excluded, 
with reasons 
(n =  1) 
 
1 study excluded because 
pure off-pump vs. on-
pump comparison was not 
provided. Instead , the 
study Compared Off-pump 
with Skeletonized ITA 
harvest vs. On-pump 
with Pedicled ITA 
harvest 
Studies included in 
qualitative synthesis 
(n =  1) 
Quantitative synthesis 






























Records identified through 
database searching 
(n = 30) 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 14) 
Records screened 
(n =  14) 
Records excluded 
(n =   13) 
Full-text articles assessed 
for eligibility 
(n =  1) 
Full-text articles excluded, 
with reasons 
(n =  1) 
 
1 study excluded because 
long-term survival (at least 
10 years) was not 
reported.  
Studies included in 
qualitative synthesis 
(n =  0) 
Quantitative synthesis 
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10.5 Systematic Review for Research Question 5 Presented in Chapter 6 
 
Purpose 
The purpose of this systematic literature search was to identify studies reporting 
the clinical outcomes of two arterial grafting strategies, SITA plus RA grafting 
and BITA grafting, in diabetic patients. 
 
Methods 
Types of Studies to be Included 
We sought to include randomized controlled trials or observational studies 
(preferentially propensity-matched) in this systematic review.  
Inclusion Criteria: Studies reporting clinical outcomes like post-operative 
mortality and morbidity and/or long-term outcomes of arterial grafting strategy 
specifically in diabetic patients were included.  
Exclusion Criteria: Studies not reporting clinical outcomes were excluded.  
Review of Studies 
This was done by a single individual rather than two independent individuals 
which is the norm for systematic reviews because it was undertaken as part of a 
doctoral dissertation.  
Searches 
Sources:  
Electronic databases like Ovid Medline, PubMed, and Embase, and the 
websites of highly relevant journals like Annals of Thoracic Surgery and Journal 
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of Thoracic & Cardiovascular Surgery were searched for studies. Reference lists 
of relevant articles were also screened.  
Search Strategy:  
The search strategy included both free text and controlled vocabulary for the 
concepts of radial artery grafts in diabetic patients undergoing coronary artery 
bypass grafting.  
Search Limitations:  
-The search was performed in September 2017, and unlike the systematic 
searches done for chapters 2 through 5, no date limits were applied as this 
paper was published in December, 2017, around the time this search was 
conducted.  
-Studies were excluded if not in English language.  
Quality Assessment 
A careful and detailed assessment of study methodology was done using the 
Newcastle-Ottawa scale.  
Data Extraction and Analysis 
Data was extracted based on a pre-specified list of elements including number 
of patients in each comparison group. Quantitative analysis was not performed.  
 
Results  
From the initial literature search, 179 articles were identified after removing the 
duplicates. Of these, 171 were excluded after title and abstract review. Of the 8 
studies [See references 1-8 below] selected for full-text review, 4 were excluded 
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because they did not provide results for diabetic patients, 1 was excluded 
because of poor study design, 1 was excluded because it was based on 
complete arterial revascularization rather than comparing different arterial 
grafting strategies in diabetic patients (see PRISMA diagram below). Table 1 
provides the characteristics of the two included studies by Hoffman et al and 
Raja et al. Quality assessment based on the Newcastle-Ottawa scale for the 























Records identified through 
database searching 
(n = 279) 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 179) 
Records screened 
(n =   179) 
Records excluded 
(n =   171) 
Full-text articles assessed 
for eligibility 
(n =  8) 
Full-text articles excluded, 
with reasons 
(n =  6) 
 
- 4 Studies excluded 
because they did not 
provide results in diabetic 
patients 
-1 Study excluded because 
of poor study design 
-1 study excluded because 
it was based on complete 
arterial revascularization 
rather than comparing 
different arterial grafting 
strategies in diabetic 
patients 
Studies included in 
qualitative synthesis 
(n =  2) 
Quantitative synthesis 






Table 1 Study Characteristics 
 
 
Study Year Patients in 
SITA+RA group 
Patients in BITA 
group 
Mean Follow-up 
Raja et al 2014 124 103 8 years 





Table 2 Quality Assessment based on Newcastle-Ottawa scale  
 
Study Design Selection Comparability Outcomes Total 





































1) Raja SG, Benedetto U, Jothidasan A, et al. Right internal mammary 
artery versus radial artery as second arterial conduit in coronary artery 
bypass grafting: a case-control study of 1526 patients. Int J Surg. 2015 
Apr;16 (Pt B): 183-9  
2) Hoffman DM, Dimitrova KR, Lucido DJ, et al. Optimal conduit for diabetic 
patients: propensity analysis of radial and right internal thoracic arteries. 
Ann Thorac Surg. 2014;98 (1): 30-6; discussion 36-7  
3) Schwann TA, Hashim SW, Badour S, et al. Equipoise between radial 
artery and right internal thoracic artery as the second arterial conduit in 
left internal thoracic artery-based coronary artery bypass graft surgery: A 
multi-institutional study. European Journal of Cardio-thoracic Surgery. 
2016;49 (1): 188-195  
4) Pevni D, Mohr R, Paz Y, et al. Long-term outcome of revascularization 
with composite T-grafts: Is bilateral mammary grafting better than single 
mammary and radial artery grafting? J Thorac Cardiovasc Surg. 
2016;151 (5): 1311-9  
5) Tranbaugh RF, Dimitrova KR, Lucido DJ, et al. The second best arterial 
graft: A propensity analysis of the radial artery versus the free right 
internal thoracic artery to bypass the circumflex coronary artery. Journal 




6) Vicol C, Raab S, Beyer M, Reichart B. Myocardial revascularization using 
the arterial T graft: which conduit should be chosen for the free graft? 
Heart Surg Forum. 2003;6(5): 353-7  
7) Caputo M, Reeves B, Marchetto G, Mahesh B, Lim K, Angelini GD. 
Radial versus right internal thoracic artery as a second arterial conduit for 
coronary surgery: early and midterm outcomes. J Thorac Cardiovasc 
Surg. 2003;126 (1): 39-47  
8) Wendler O, Hennen B, Markwirth T, Nikoloudakis N, Graeter T, Schäfers 
HJ. Complete arterial revascularization in the diabetic patient--early 
postoperative results. Thorac Cardiovasc Surg. 2001;49 (1): 5-9 
 
 
